







OPTIMISM, HEALTH LOCUS OF CONTROL, AND QUALITY OF LIFE 
WOMEN WITH INITIAL VERSUS RECURRENT BREAST CANCER 
Gina Graci, B.A., B.S., M.S.   
 
 
Dissertation Prepared for the Degree of 
 
















Chuck A. Guarnaccia, Major Professor 
Kimberly Kelly, Committee Member 
Richard A. Lusky, Committee Member 
Michael J. Mahoney, Committee Member 
Ernest H. Harrell, Chair of the Department of Psychology 
Neal Tate, Dean of the Robert B. Toulouse School of  
Graduate Studies 
UNIVERSITY OF NORTH TEXAS 
May 2001 
Graci, M. Gina, Optimism, Health Locus of Control, and Quality of Life 
 
of Women with Initial versus Recurrent Breast Cancer.  Doctor of Philosophy (Clinical 
Psychology), May, 2001, 129 pp. 12 tables, 3 illustrations, references, 98 titles.  
Health Locus of Control (HLOC) and other predictors of Quality of Life (QL) 
were examined for women with an initial versus recurrent breast cancer diagnosis. 
Twenty-eight women with an initial breast cancer (IBC) diagnoses and twenty-eight 
women with recurrent breast cancer (RBC) diagnoses were recruited from doctors’ 
offices and cancer support groups. Correlational analyses were used to assess the 
relationships between variables. No significant differences were found between women 
with IBC and RBC on Psychological QL. Doctor HLOC and Psychological QL were 
related for women with RBC (r = .481, p = .01) and marginally so for women with IBC (r 
= .329, p = .09). A positive correlation was also found between Doctor HLOC and 
Functional QL for both women with IBC (r = .464, p = .01) and women with RBC (r = 
.390, p = .04). After controlling for stage of cancer, women with RBC reported higher 
Functional QL than did women with IBC. Advanced (stages III or IV) versus early 
(stages I or II) cancer stage related to lower Functional QL, controlling for initial versus 
recurrent diagnosis (r = -.283, p = .01). A marginally significant relationship was also 
found for cancer stage, regardless of initial versus recurrent diagnosis, with higher 
Overall QL for women with early stages of breast cancer (r = -.157, p = .09). No 
significant differences in Optimism or Overall QL were found between women with IBC 
versus RBC. No differences were found between married and single women. This 
research begins to explore differences in Quality of Life for women with a new versus a 
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Reasons for the Study of Quality of Life (QL) in Breast Cancer (BC) Patients 
Cancer is a general term used to describe over 100 diseases that are characterized 
by the malignant spread of abnormal cells in the body (American Cancer Society, 1993).  
Breast cancer (BC) is the most common cancer in women, accounting for one out of 
every three cancer diagnoses (American Cancer Society, 1999).  Breast cancer mortality 
rates are highest amongst women aged 30-to-50 (Ganz, Hirji, Sim, Schag, Fred, & 
Polinsky, 1993; Royak-Schaler, 1992) and the leading cause of death in women aged 15-
to-54 years (American Cancer Society, 1999).  Women aged 50 and older are more likely 
than younger women to receive a cancer diagnosis.  However, women less than 45 years 
who are diagnosed with breast cancer have a 79% five-year survival rate, whereas this 
rate increases to 84% for women aged 45 to 64 and to 87% for those women 65 years and 
over (American Cancer Society, 1993). 
In addition to age, ethnicity has become a significant factor in mortality rates 
because Caucasian women are more likely to develop breast cancer than other ethnicities. 
However, African American and Hispanic women are more likely to die of breast cancer 
than Caucasian women due to unavailability of treatment and stage of cancer at diagnosis 
(American Cancer Society, 1999). 
 Recurrence is defined as the reappearance of the disease that was thought to be 





by location, that is local (cancer came back in same place), regional (growth of a new 
tumor in lymph nodes or in tissue near the original site of cancer), or metastatic (cancer 
spread to organs or tissue far from the initial cancer site).  If a patient is diagnosed with a 
breast cancer recurrence, this diagnosis does not necessarily mean a “death sentence.”  
Many recurrences are localized to the original cancer site and not indicative of metastatic 
cancer.  This type of recurrence diagnosis yields high survival rates.  
Exact estimates of BC recurrence are not available; however, many women with a 
history of BC experience a recurrence (Mahon & Casperson, 1995). Reactions to a 
recurrent diagnosis vary according to several factors: location and stage of cancer, 
treatment options, and prognosis of the disease (Christ, 1993). There is general consensus 
in the cancer literature that a recurrent diagnosis is threatening at all levels (Mahon et al., 
1995) and that a recurrent diagnosis causes patients to re-experience feelings of 
psychological distress that were present at the initial diagnosis with loss of optimism and 
hope of a future (Christ, 1993; Holland, 1998; National Institutes of Health, 1992).  Not 
only does the disease threaten the life of the patient, but a cancer diagnosis also holds 
further implications for psychological, physical, and functional well-being in addition to 
the changes in social experience.  However, reactions to recurrence may not be as 
devastating as the initial diagnosis because many patients may have learned certain skills, 
knowledge and supports that have aided them in working through the prior cancer 
experience (Christ, 1993; Holland, 1998; Mahon, et al. 1995). 
To date no studies have been conducted comparing women with an initial versus a 
recurrent BC diagnosis.  It is hypothesized that both types of diagnoses (initial or 





psychological distress for the patient.  However research has not been conducted on how 
both types of patients experience cancer, so one can only speculate how women with an 
initial versus a recurrent diagnosis will react to the cancer experience.  For instance, once 
treatment ends, women with either an initial or recurrent diagnosis may be apprehensive 
about the future because of the fear of a (another) cancer recurrence.  This fear may 
diminish over time as long as the individual remains in remission, however, the 
consensus is that it never completely disappears (Christ, 1993).   
 Advances in medical treatments during the last two decades have not only 
increased survival time but also improved the quality of life for BC patients.  More than 
50% of BC patients are in remission for at least five years after a primary treatment with 
surgery and chemotherapy, radiation therapy, or hormonal therapy. These treatments are 
often quite toxic and many compromise a patient’s physical, psychological, and social 
well-being. Side effects of these treatments can also increase pain as well as debilitation, 
limiting an individual’s ability to function at work, regulate mood, sleep and participate 
in physical activities and social relationships (Cleeland, 1990 as cited in Ahles, 1993).  
Recurrent patients may experience even more debilitation and reduction in quality of life 
than a patient experiencing cancer for the first time because recurrent cancer therapies 
utilize more aggressive treatment methods.  Nonetheless, both types of patients, in 
addition to the psychological and physical distress, have to confront serious issues 
related, but not limited to: health insurance, finances, employment, and interpersonal 
relationships. 
Neither the needs, perceptions, nor psychosocial concerns of patients with 





have to revise their initial optimism and hope for a cure after a recurrence diagnosis since 
the average length of survival decreases significantly with repeated episodes of the 
disease (Holland, 1998; Worden, 1989).  Patients having been in remission for a long 
(e.g., ten years), as compared to a short length of time (e.g., two years), may be especially 
susceptible to the stress associated with a BC recurrence diagnosis (Holland, 1998; 
Mahon et al., 1995; Worden, 1989), as these long-term survivors may again view 
themselves as being healthy.   
Although progress in cancer treatment continues, recurrence of BC is still 
considered to be a poor prognostic sign (Worden, 1989).  Treatment goals for recurrent 
BC may differ from treatment goals for an initial diagnosis of BC.  The goal, from a 
medical and psychological perspective, in treating recurrent BC cancer may be to 
increase patient’s quality of life by helping patients adjust and cope with the disease, 
increase compliance and treatment, and to detoxify death by helping patients to face their 
potential loss(es) (Mahon et al., 1995).  These losses include long-term cure and long-
term survival being less likely for recurrent BC patients.   
Since there is a paucity of recurrent cancer research, one can only speculate about 
how women with an initial versus recurrent BC diagnosis will react to their cancer 
experience.  The goal of this study is to determine if differences exist between these 
groups of women and to gain a greater understanding of the cancer experience from these 
two different perspectives. 
Conceptualization of QL 
Quality of life research (QL) has been of interest to researchers for several decades dating 





toxicity (Cella, 1992), and progression/severity of the disease/illness. These were not 
considered to be adequate measures of psychological, social, functional, and physical 
domains of a patient’s life. Although current research has concerned itself with 
improving not only “quantity” but also the “quality of life of a person” (Cella, 1989) by 
focusing on the physical, emotional, and social dimensions of well-being (Aaronson, 
1990; Ganz & Coscarelli, 1995; Ringdal, 1996), many cancer treatment clinical trials do 
not include QL measures.  Gotay & Wilson (1998) reviewed 1,504 articles on cancer 
treatment clinical trials from 1992 to 1996 and less than 5% of these articles focused on 
patient ratings of QL.  While cancer research has broadened to incorporate QL issues, 
there is a scarcity of empirical QL research, possibly preventing clinical interventions 
from improving QL in cancer patients. 
 Cella (1989), and Nanda and Andresen (1998) stress the importance of associating 
QL to changes in health status.  They suggest that QL is a dynamic construct that changes 
over the course of an individual’s life, especially when illness strikes. Self-reported 
measures of QL domains provide a measure of health from the patient’s perspective. 
Factor analytic studies have suggested that there are essentially four QL domains: 
functional, psychological, social, and physical status (Aasonson, 1986; Schipper et al, 
1984; Stewart et al, 1981, as cited in Cella, 1983; Gotay, et al., 1998; Rummans et al., 
1998).  However, QL research has been problematic because the domains have been 
difficult to operationalize and repeatedly undergo conceptual revision.  As a result, QL 
has become a difficult construct to measure.  Furthermore, QL may mean many different 
things to various professionals within multiple settings (Lindley, 1992).  Wellisch (1983) 





definition of the QL construct. Using factor analytic studies could potentially aid 
researchers in determining the underlying dimensions of QL; however, these measures 
are rarely reported because many of the QL measures were developed and validated on an 
insufficient number of participants. 
Two key aspects of QL are often employed in defining the construct;  subjectivity 
and multidimensionality (Aaronson, 1989; Cella, 1992; 1994 Ganz et al., 1995; Ringdal, 
1996; Rummans et al, 1998).  Subjectivity refers to understanding QL from the patient’s 
own perspective (Cella, 1992; 1994) rather than being based on objective medical, 
physiological, or functional measures. This information may include perception of 
illness, perception of treatment, expectations of self, and appraisal of risk/harm. 
Measurements of overt behavior fail to account for the patients’ perceptions of QL 
because cognitive processes that mediate these perceptions of QL are often neglected 
(Cella, 1989; 1994) and provide an incomplete assessment of the QL construct.  
 The second component of the QL concept, multidimensionality, assesses multiple 
domains of patient functioning (Aaronson, 1988;1989; Barofsky, 1984; Cella, 1994; de 
Haes, 1985; Ganz et al., 1995; Gotay et al., 1998; Lindley, 1992; Rummans et al., 1998; 
Ware, 1984).  These domains have been partitioned into four quality of life domains as 
illustrated in Figure 1.  The areas include: (a) Functional Status, including ratings of 
mobility, self care, physical activities, and role activities, such as employment or 
household responsibilities (Aaronson,1988; 1989; Ganz et al., 1995; Holland, 1998); (b) 
Psychological status, including levels of anxiety, depression or other nonspecific forms of 
distress that may be secondary to the disease itself or its progression and/or treatment 





Worden & Weisman, 1984); (c) Physical Functioning, also referred to as Disease and 
Treatment-Related Symptoms, involving specific symptoms from the disease such as 
pain or shortness of breath, or side effects of drug therapy such as nausea, hair loss, 
impotence, or sedation (de Haes & Van Knippenberg, 1985; Ganz et al., 1995;); and (d) 
Social Functioning, including the ability to maintain social interactions (Ganz et al., 
1995).  
 These four domains of QL affect all aspects of an individual’s life.  QL must take 
into account these domains because each one has an unique influence in how a person 
interacts with others and life and copes with adversity.  The importance of the QL 
construct becomes apparent because the four domains have significant influence on how 
satisfied an individual is with their life from a psychological, functional, social, and 
disease-treatment related perspective.   
 The theoretical relationship of these indicators of QL is shown together in Figure 
2, with the original model being adapted from Tchekmedyian, Hickman, Siau, Greco, and 
Aisner (1990).  This model was initially revised by deleting health care related, life 
satisfaction variables, and adding more relevant life satisfaction variables as indicators of 
psychological well-being. Psychological and functional status variables have also been 
retitled Psychological QL and Functional QL and will be referred to as such from this 
point on.  Quality of life is modeled as the construct of interest and is causally determined 
by Psychological QL, Social QL, Functional QL, and Disease-Treatment-Related 
Symptoms.  These four influential constructs are composites of the variables shown. 
  Additional considerations that are important in the evaluation of QL include: 





family functioning, sexuality and body-image, and treatment satisfaction (Aaronson, 
1988; 1989; Cella, 1989; 1994; Ganz et al., 1995; Ganz et al., 1993; Ware, 1993). Several 
researchers suggest that these additional factors are important to assess but are not 
adequately captured by a linear four-dimensional model as shown in Figure 1 (Aaronson, 
1990; Cella, 1989; 1992).   
Aaronson and Cella also argue that these areas are important to cancer patients; 
however, they appear to be separate, independent dimensions of QL.  Since factor 
analytic studies have not been conducted on sufficient sample sizes, it is hypothesized 
that these factors only affect overall QL under specific circumstances and are illustrated 
as such subordinate dimensions in Figure 2.  Nonetheless, these subordinate domains are 
suggested to be associated with several of the QL domains (Cella, 1989).  For instance, 
both physical and functional statuses, as well as psychological status, mediate sexual 
functioning.     
The concept of QL involves more than individual components such as physical 
well-being, disease progression, and/or pain at any given point.  A patient’s response to 
disease and treatment should not be an acceptable QL measure, rather measures of QL 
are most effective when they address the related domains of functional, psychological, 
and social status. Each of these factors contributes to the general sense of well-being and 
help constitute quality of life. QL, therefore, refers to patients’ appraisal of, and 
satisfaction with, their current level of functioning when compared to what they perceive 
is possible or ideal (Cella & Cherin, 1988).  This value-based rating has utility because it 
provides a patient’s subjective opinion about the stress related to treatment and disease. 





objective perceptions of patient illness and pinpoint the actual level of disability 
experienced within multiple domains. 
 Cella (1992) poignantly illustrates this “level of actual disability” experienced. He 
proposes that, although two patients may experience the same degree of nausea, they may 
experience very distinct disruptions in social or daily living.  This difference could be due 
to differences in the emotional reaction to the nausea, or to differences in patient role.  
One patient may be able to function adaptively with the nausea, while the other’s 
adaptive capacity is severely weakened.  Thus, both patients may have comparable 
survival rates; however, one patient significantly experiences a reduced QL (Gotay et al., 
1998). 
Lastly, it is important to realize that components of QL overlap with each other; 
they are interdependent as opposed to independent (Cella, 1992, 1994). For instance, a 
patient’s experience of depression may affect their rating within both psychological and 
physical domains of QL.  Thus, a valid measurement of QL must account for the 
interdependence of these variables and the influence of contextual factors such as phase 
of treatment and frequency of remission.  The QL construct is becoming more valued as 
an indicator of life satisfaction across multiple life domains and during all phases of the 
cancer treatment cycle, from initial diagnosis through cure, extended remission, or death 
(Cella, 1992).  Empirically, the use of a dialectical perspective, accounting for multiple 
factors seems most appropriate. 
 To date, selected researchers (Aaronson, 1988; 1989; 1990; Cella, 1992, 1994, 
1996; Cella et al., 1987) have gathered information from each of the individual 





develop a composite measurement of the QL construct.  This operationalized, dialectical 
approach is believed to be useful because it incorporates a patient’s overall experiences 
across different phases of the cancer process. A major concern regarding the use of this 
operationalized definition has been raised by several researchers (Aaronson, 1990; Cella, 
1989; 1992, 1994, 1996; Rummans et al., 1998).  They posit that the use of a composite 
index to assess broad, often subjective experience can result in inaccurate, unreliable, and 
incomplete data.   
The general findings in the literature do not provide much information on the 
separate components of QL, such as functional and psychological QL, because composite 
scores are typically used.  In terms of functional QL, it appears plausible that BC patients 
with higher functional abilities will be more protected from fatalistic and hopelessness 
perceptions than individuals with lesser functional abilities. Furthermore, it is difficult to 
determine if symptoms are related to psychological disturbance or are directly related to 
the disease and treatment.  When assessing QL, physical and psychological QL may have 
overlapping constructs, which can confound measurement of reported QL domains. 
While composite scores may be useful for a global QL assessment, they do not provide 
insight into areas of an individual’s experience, which influence their QL scores. For 
instance, a person may report good social and functional QL, while their physical or 
psychological health is poor, resulting in an average QL score. It is apparent that 
composite scores do not provide information that is helpful in improving the areas of a 
patient’s health that is unsatisfactory.   
Additionally, Aaronson (1989) cautions the researcher from using instruments 





psychological QL.  This cautionary especially relates to patients with late stage cancers 
because in addition, the physical effects of illness may have psychological effects 
(Burgess, Morris, & Pettingale, 1988).  QL assessment of late stage cancers has been 
problematic because of the cognitive deficits, severity of physical symptoms, and 
psychological disability of patients, preventing them from providing much needed QL 
information ( Grassi et al., 1996). 
 Lastly, Cella (1996) suggests that assessing the psychological, physical, 
functional, and social domains of QL may be difficult to cover in a single brief 
questionnaire.  Since QL research has important implications for cancer patients, and 
since measurement issues pose problems, investigating a couple of QL domains and 
applying it to a cancer population holds significant clinical importance.  Although 
combining measures of QL domains to approximate a single index of QL has been 
suggested (Stewart, Ware, & Brook, 1981), Cella (1989; 1996) cautions the researcher, 
because not many validity studies have been performed on many of the existing QL 
measures and measurement issues must be taken into consideration. 
 The diversity of the different components of QL is essential when discussing 
overall satisfaction with life or general sense of patient well-being.  This discussion of 
QL domains will be limited to psychological and functional components.  Psychological 
and functional QL are used interchangeably with psychological and functional quality of 
life.   
Psychological/emotional well-being and the ability to function in everyday life 
have not been thoroughly investigated in the literature, and research into these separate 





versus a recurrent diagnosis evaluate and manage life. The theoretical formulations of 
factors having most significance for clinical intervention are functional and psychological 
QL.  Since the physical dimension may overlap considerably with the psychological and 
functional QL domains, it is difficult to isolate the factors involved in the latter 2 
domains.  Additionally, medical treatment can be provided to alleviate many of the 
physical symptoms associated with cancer disease, but treatment may not be appropriate 
for someone who has lost functional abilities.  Research suggests that lose of role 
functioning, for instance, can produce psychological symptoms such as depression.  
Therefore, investigating these two domains will bring about greater insight in 
understanding how cancer affects a person’s life both from a psychological perspective, 
as well as a functional one, and promote useful interventions.   
Use this template for the format of your document. Use your disciplinary style 
manual for guidance regarding the content and structure of figures, tables, citations, and 
references, treatment of special terms and symbols, additional, or other subheadings and 
subheading styles (if you need subheadings with numbers, for instance or if you wish to 
use sentence style for subheadings rather than the headline style shown here); for rules of 
usage with regard to technical language and stylistic conventions, as well as other 
discipline specific issues. 
Functional QL.  The functional dimension of quality of life is correlated with but 
sufficiently different from the physical dimension because many of the physical 
symptoms (i.e., treatment side-effects, bodily function/dysfunction or weight loss) 
overlap with psychological QL (i.e., loss of appetite, fatigue, or weight loss)(Aaronson, 





Stewart et al., 1981).  Functional QL incorporates an individual’s personal needs, 
ambitions, and social role.  At the most basic level, these abilities include instrumental 
activities of daily living (IADLs), which are walking, feeding, bathing, and dressing 
oneself.  Additionally, it also incorporates an individual’s ability to carry out 
responsibilities not only inside the home but those with family, friends, and colleagues 
(Cella, 1989; 1992). Physical and functional components of QL can be independent of 
one another, especially when an individual is able to continue to function in his/her work 
environment effectively despite physical discomfort and/or weakness caused by treatment 
(Cella, 1989; Rummans et al. 1998).   
 Ditto, Druley, Moore, Danks and Smucker (1996) evaluated the importance of 
valued life activities in health-state evaluations.  Valued life activities were defined as 
any activity or activities that an individual perceives as pleasurable or meaningful, 
ranging from simple daily tasks (e.g., reading or listening to music) to interactions with 
family and friends and ability to care for oneself. The authors suggest that cognitive, 
functional, and physical dysfunctions, as well as pain only affect QL ratings when 
individuals perceive these dysfunctions to prevent them from engaging in their valued life 
activity.  If receiving a cancer diagnosis or living with cancer interferes with an 
individual’s ability to engage in their valued life activities, then a decrease in QL ratings 
occurs.  For example, a cancer patient who enjoys reading is likely to have higher QL 
ratings than someone who is not able to hike or golf (if these were valued life activities) 
due to side effects of cancer treatment.  These authors further suggest that given a 
particular health state, individuals will calculate their perceived QL based on the amount 





or psychological dysfunctions. The theoretical relationship of valued life activities and 
QL domains is illustrated in Figure 3. 
Cancer tends to limit both functional ability and role performance and these 
limitations can affect patients’ expectations of themselves as the disease progresses.  Pain 
becomes relevant to discuss because not only can it be a component of disease symptoms, 
it can also affect an individual’s functional QL (Cella, 1989; Holland, 1998; Rummans et 
al. 1998).  For instance, many studies have found pain to significantly influence a 
patient’s ability to function, which, in turn, affects overall QL.  Rummans et al. suggests 
that pain involves cognitive, motivational, behavioral, psychological, and physical 
components, which all greatly contribute to QL.   In Rummans’ study, half of their 
female participants with either recurrent breast or gynecologic cancers experienced mild-
to-moderate pain.  This mild-to-moderate pain level correlated with the physical QL 
domain; however, many of the items related to the functional and social dimensions.  
These correlations were also not as strong between pain and psychological and spiritual 
dimensions.   
Besides recovery, the primary goal for patients is to maximize their function in 
everyday life and to achieve the highest level of psychological well-being. Both 
functional and psychological QL are highly valued by patients and these are essential 
outcomes of medical care (Rummans et al., 1998; Stewart et al., 1989; Ware, 1989).  The 
goal of maximum functioning may hold even greater importance for recurrent cancer 
patients.  Silberfarb, Mauer, and Crouthomel (1980) compared functional QL of BC 
patients undergoing either primary treatment, recurrent treatment, or palliative care 





this 1980 study will center on its comparisons between palliative and recurrent treatment. 
Silberfarb et al. found recurrent BC patients in active treatment needed more help with 
functioning than did the terminally ill patients in the palliative care group.  The recurrent 
BC patients also had more reported difficulties with daily routine issues and with 
depression than did the palliative care patients.     
Osoba et al. (1996) compared functional status of recently diagnosed brain cancer 
patients to those with a brain cancer recurrence.  The authors reported that recently 
diagnosed patients had fewer functional problems than patients with recurrent brain 
cancer.  It is plausible that a diagnosis of recurrence lowers one’s optimism and increases 
both psychological distress and fatalism.  The decrease in functional abilities may also be 
related to more aggressive therapies that may be used to treat a cancer recurrence.   
 Employment status, as the proportion of patients who are working, is also affected 
by type of cancer and treatment.  Barofsky (1984) reported that blue-collar workers are 
less able to sustain their previous level of activity than are higher paid white-collar 
workers.  Thus, the burden of cancer and its treatment can differentially impact the 
functional domain of an individual’s life independent of disease severity.  These 
differences may involve a patient’s cancer status or their role functioning. For example, 
physical limitations may not affect role performance (employment status), and there may 
be occasions of role dysfunction in the absence of physical limitations (Grassi et al., 
1996; Rummans et al., 1998; Stewart et al., 1981). 
Few studies have examined the relationship between age and QL in women with 
BC (Ganz, Lee, Sim, Polinsky, & Schag, 1992; Vinokur, Threatt, Vinokur-Kaplan, & 





positive relationship between age and better QL in women newly diagnosed with BC.  
Ganz et al. (1992) found that age did not predict QL in newly diagnosed BC patients. 
Ganz et al. did report a weak relationship between age for elderly, newly diagnosed BC 
patients and QL, indicating evidence for better QL with advancing age. However, Graci 
(1998) in a QL study investigating, health locus of control beliefs, optimism, and 
psychological and functional QL in women with recurrent BC found a significant positive 
correlation between restriction of activities and psychological distress for women aged 65 
years and older.  Age also did not relate to a lower functional QL. It seems plausible that 
the relationship between age and QL may be a complex multivariate relationship. 
 Problems in QL research rest on the notion that if a disease does not cause 
behavioral dysfunction than it does not have personal/social implications.  Ware (1983) 
reported that role functioning is only very weakly related to emotional functioning 
(mental health).  However, psychological distress has been found to impact functional 
QL, specifically at the level of personal and role functioning. A BC patient may not be 
experiencing significant psychological distress but may have limitations on her functional 
ability.  Grassi et al. (1996) investigated QL ratings of homebound patients with 
advanced cancer patients, as well as ratings by family members and oncologists.  The 
researchers reported that reduction in role performance or onset of treatment side-effects 
did not necessarily result in low ratings of psychological or social QL.   
     Psychological QL.  The psychological dimension of QL is also correlated to, but 
distinct from, the physical and functional dimensions (Cella, 1989; 1992; Hays & 
Stewart, 1990; Rummans et al., 1998).  Psychological QL refers to the mental health 





disease progression, or side-effects of treatment (Greer & Silberfarb, 1982; Worden & 
Weisman, 1984). Common psychological feelings include volatility of emotion, guilt, 
depression, fatigue, resurfacing of unresolved issues, negativity, and strong attempts to 
remain in control (Christ, 1993; Holland, 1998; Mahon et al., 1995). Cella (1989) argues 
that the psychological domain is bipolar in that its spectrum goes from positive affect 
(well-being) to negative affect (distress).  Ideally, researchers should assess a patient’s 
psychological functioning at the onset of cancer and treatment, as well as during disease 
stability.  Cella hypothesizes that during the onset of cancer and treatment, a reduction in 
psychological QL may occur due to blunting of positive affect experienced by the patient. 
 The diagnosis, course, and treatment of cancer have extensive psychosocial 
consequences for the BC patient and her family.  There is considerable evidence that 
early stages of BC and its treatment are associated with psychological distress, sexual 
dysfunctioning, and social morbidity (Christ, 1993; Fallowfield, Baum, & Maguire, 1986; 
Morris, Greer, & White, 1977; Holland, 1998; Morris & Ingham, 1988).  De Vita, 
Hellman and Rosenberg (1993 as cited in Gotay et al., 1998) suggest that diagnosis and 
treatment of cancer affects psychological functioning and disrupts family and 
employment activities.   
Unfortunately, less research has focused on the psychosocial aspects of recurrent 
cancer.  Graci (1998) utilized a composite score for the functional and psychological QL 
domains when investigating whether advancement in cancer stage would related to lower 
functional and psychological QL.  This research did not find significant mean differences 
between cancer stages and QL ratings, a surprising result because the majority of cancer 





psychological QL.  It is plausible that many of these individuals relied on social support 
systems, which buffered the stress associated with advancement of the disease and the 
functional impairment experienced.  It is also likely that many of the participants retained 
their valued life activities so they were still able to enjoy some of their valued activities 
such as reading, playing cards, listening to music, or watching television. 
 There is general support for the relationship between disease progression and 
severity of treatment and psychological well-being (Anderson, 1992).  Cella  et al. (1987) 
examined psychological distress in lung cancer patients and found that the extent of 
disease and physical impairment from treatment based on composite scores was a 
predictor of magnitude of mood disturbance.  DeHaes, Van Oostrom, and Welvaart 
(1986) reported overall QL was related to extent of treatment for BC:  radical surgery or 
breast conserving surgery.  Patients undergoing breast-conserving surgery reported higher 
QL than patients receiving radical treatment.  However, patients receiving breast-
conserving surgery reported more fears of cancer recurrence.  However, Cella et al. 
(1987, as cited in Grassi et al., 1996) found that reduction in functional status did not 
necessarily cause a reduction in psychological or social functioning.   
Few studies have examined the relationship between age, psychosocial 
adaptation, and QL in women with BC (Ganz et al., 1992; Ganz, Schag, & Heinrich, 
1985; Vinokur, Threatt, Vinokur-Kaplan, & Satarino, 1990).  Several researchers have 
found that groups of older individuals with chronic medical conditions and cancer report 
better mental health than younger individuals (Cassileth et al., 1984; Feinson, 1985; Ganz 
et al., 1992; Ganz et al., 1985).  Ganz et al. (1992) investigated the relationship between 





weak, negative relationship with younger women fairing slightly better.  However, post 
hoc analyses revealed a positive relationship between age and better psychological and 
social status in married women.  Married women were also found to have less mood 
disturbance with increasing age as annual household income declined.  The authors 
offered no explanation for these possible chance findings.  However, Graci (1998) in her 
recurrent BC study did not find a significant relationship between having a significant 
other and higher functional and psychological QL.  The findings suggest that the cancer 
experience is distressing at all levels and may be just as distressing for a woman in a 
marriage or significant relationship as it is to someone who is single. 
 Research studies show that many cancer patients suffer considerable distress from 
the implications of their recurrent diagnosis as well as from the progression and treatment 
of their disease.  deHaes and Welvaart (1985) reported older BC patients, after primary 
treatment, reported less fear of recurrence and death than younger patients.  Additionally, 
Worden (1989) assessed the emotional and psychological QL of patients with recurrent 
cancer.  Younger recurrent patients were found to be more distressed than older patients.  
These younger patients were also more likely to blame themselves for their disease 
recurrence.  The time from initial diagnosis to recurrence and the time from last treatment 
to recurrence was not found to be significantly correlated with distress levels.  This 
finding is somewhat contrary to the research of Mahon et al. (1995) and Worden (1989). 
Weisman and Worden (1986) in a study of 102 patients diagnosed with recurrent cancer, 
found a relationship between the degree of distress experienced at time of recurrence and 
degree of expectation of recurrence.  Those individuals who were surprised by their 





believed their disease to be cured, experienced the least amount of distress. Surprisingly, 
these researchers also found no evidence that a recurrent cancer diagnosis is more 
distressing than the initial diagnosis.  Holland (1998) suggests that when a patient is 
diagnosed with a recurrence, the experience is similar to that experienced at the initial 
diagnosis.  She proposes that the emotional turmoil (sadness, depression, etc.) is 
intensified because a patient has to cope with the idea that treatment (the greatest hope 
for cure) has failed and their mortality is threatened. Holland reports that physicians who 
educate the recurrent BC patient about what constitutes a cancer recurrence and outline a 
revised treatment plan help alleviate the anxiety and depression experienced. 
Graci (1998) investigated whether age impacted the relationship between 
psychological and functional QL in recurrent BC patients.  The initial hypothesis was that 
for individuals at 65 years of age and older will report more restriction of activities and 
distress. These hypothesis was not supported.   Women in both age groups did not report 
a decrease in functional or psychological QL. It is plausible that both groups of women 
receive adequate emotional support and assistance to buffer the deleterious effects of the 
diagnosis, treatment, and cancer progression.   Younger women tend to be in physically 
better health than older women; they may not have the functional role loss that older 
women experience from treatment and/or cancer progression.  If functional abilities 
become compromised, younger women may be more willing to engage help from others.  
For example, younger women may need help with care-taking for their children.  
Assistance from others, not only helps them cope better because they are not forsaking 
their responsibilities, but it lessens the functional/physical burden (e.g., side-effects from 





psychological well-being.  If a person is able to self-care (regardless of their age or if 
assistance was necessary), psychological well-being may not be compromised.   
Additionally, adaptive coping methods may be employed by both age groups to 
enhance psychological QL. In this sample, younger women were less likely to have 
advanced cancers, suggesting a better prognosis.  Younger women diagnosed with earlier 
stages may also be more optimistic about their prognosis, reflecting higher QL ratings.  
Younger women may also engage in more problem-focused coping, which preserves their 
psychological QL. It is plausible to suggest that the psychological and functional 
dimensions of QL can both independently and jointly buffer the deleterious affects of the 
cancer process.  Based on this statement, one may see how a positive relationship 
between these variables would exist. 
 Since the majority of studies on cancer are conducted on patients with early-
staged disease, QL research does not have adequate information on QL ratings of 
advanced-staged cancer patients.  While the focus of this study is not on pain and its 
relationship to QL, one must take into consideration the role that pain has on 
psychological functioning.  Rummans et al. (1998) reported that as patients’ pain 
experience increases due to advancement of disease, their psychological ratings decline. 
He hypothesizes that as pain increases, that is goes from mild to severe, anxiety and 
depression increase.  Glover et al. (1997) as cited in Rummans et al., 1998) found that as 
pain intensified, psychological distress increased and total mood disturbance rose.  These 
findings are important for BC patients experiencing side-effects of cancer treatment.  As 
pain or discomfort increase, psychological QL ratings may decline.  This statement may 





treatment modalities used are aggressive and may produce significant pain and 
discomfort. 
 Tross and Holland (1998) and Christ (1993) discuss extended psychological 
responses to cancer.  These responses include fears of recurrence, continued 
preoccupation with cancer, increased fears of death, greater uncertainty about the future, 
increased feelings of anxiety and depression, loss of sense of control, fear of social 
rejection, increased sense of personal inadequacy, and job insecurity.  This extended 
psychological morbidity is hypothesized to affect long-term survivors.  Longitudinal 
studies are currently investigating this phenomenon.  
Christ (1993) reported that 104 cancer survivors having been out-of-treatment for 
at least one year had a significantly lower sense of self-control and more general health 
worries than a healthy control group. It is important to emphasize that psychological 
functioning primarily depends upon the stage of BC identified at time of diagnosis, 
treatment plan, and prognosis (Tross et al, 1998), as well as the age and coping strategies 
available to women diagnosed with initial or recurrent BC diagnoses. 
 Holland (1998) suggests that patients, either receiving an initial or recurrent 
diagnosis, tend to search for the cause of their disease.  Some BC patients blame 
themselves, the doctor, or fate as having caused their disease.  These patients have to 
struggle with trying to control their emotions as well as  plan the best treatment modality. 
Health Locus of Control 
 The meaning of health can be an ambiguous term because health can refer to an 
individual’s predisease state, or it may refer to a person’s current experience with disease 





can influence their health through either personal factors, such as willpower to cure a 
cold, or by using external resources, such as visiting a doctor to alleviate symptoms of a 
cold. In this sense, health may be perceived as a variable that is controllable. The belief 
that an individual’s health is or is not determined by behavior is a health locus of control 
belief (Wallston & Wallston, 1978).  Health locus of control is defined as the beliefs an 
individual has over the control of their health (Wallston, Greer, Pruyn, & Van Den Borne, 
1990; Wallston, Stein, & Smith, 1994). A person can believe that personal, internal, 
factors or situational, external, factors control health. Wallston et al. (1994) reported 
health locus of control orientation is not only mediated by an individual’s behavior but it 
is an “indirect determinant of health status” (p. 535).  These researchers assert that health 
beliefs are learned over the course of an individual’s lifetime and become the function of 
prior health status and health-related experiences. 
 The health locus of control belief system was adapted from Rotter’s (1966) locus 
of control theory. Locus of control is defined as the belief that an individual has personal 
control over a variety of life circumstances (Danke et al., 1994; Lewis, 1982).  Locus of 
control is a personality variable derived from Rotter’s (1966) social learning theory.  He 
cites that individuals have various psychological resources and among these resources are 
certain beliefs in either an internal or external locus of control playing an active role in an 
individual’s appraisal of an event.  Locus of control is commonly referred to as being an 
expectancy belief because it involves dealing with the source of the control over an 
outcome (Smith, Wallston, & Smith, 1995; Wallston, 1991). This belief of control can 
determine how a person will react to social, physical, and emotional stressors and can 





becomes an important strategy for a woman afflicted with cancer.  Her coping strategies 
may be influenced by her beliefs regarding the personal control she has over her 
health/cancer.  
Both the locus of control and health locus of control construct are composed of an 
internal or external orientation. For example, a BC patient may actively search for a 
causal explanation of her disease.  Depending on her control beliefs, she may believe her 
state of health is internally or externally controlled. An individual with an internal view 
regarding health believes that if she remains in good health or if her disease progresses, it 
is the result of her behavior.  In comparison, an individual with an external health locus 
of control orientation believes that other factors, such as luck, chance, or fate determine 
the state of health.  Additionally, individuals may feel that their health is influenced by 
other powerful factors (e.g., health professionals) over which they have little control 
(Smith et al., 1995; Wallston et al., 1978; Wallston et al, 1994).  
Unlike the locus of control construct, the health locus of control construct is 
viewed as a multidimensional construct (Wallston, 1991; Wallston, et al., 1994; Wallston 
et al, 1978).  While both constructs are composed of internal and external superordinate 
poles, the health locus of control orientation is composed of internal, powerful others, and 
chance factors.  The saliency of the health locus of control belief system (i.e., health 
controlled by self, powerful others, or chance factors such as fate) becomes apparent 
because it invariably plays an integral role in contributing to cancer patients’ perception 
of QL. 
Wallston et al. (1994) theorizes that people with varying health conditions may 





health status.  For instance, a cancer patient may hold an external orientation regarding 
her cancer while at the same time believe that she can influence other aspects of her 
health. She may believe that a “powerful other” is in control of the fate of her disease, yet 
maintain that she can control her arthritis by resting often, eating properly, and limiting 
stressful activities. 
Dahnke et al. (1994) and Graci (1998) challenge the stability of the health locus 
of control construct, suggesting that the construct might fluctuate at different 
points/stages in an individual’s disease. They also suggest that an individual’s perception 
of disease control in earlier stages may be different from perception of disease control in 
later stages. For example, a BC patient diagnosed with Stage I cancer might have an 
internal orientation regarding her health; whereas, a BC patient diagnosed with a Stage 
IV (late/terminal stage) cancer may perceive her health as being controlled by external 
factors (powerful others, God).  
Little is known about the meaning of experienced personal control or its 
relationship to QL in cancer patients, especially late-stage patients (Lewis, 1982; 
Weisman, 1979). The literature presents contradictory findings regarding cancer and 
control beliefs.  Lewis (1982) reported that patients who take an active, decisive role in 
their cancer treatment and disease are believed to maximize their sense of control and 
experience higher levels of psychological QL. This higher level of QL reported appears 
to be a function of a generalized sense of control over an individual’s life and not 
necessarily control over their health.  Christ (1993) further supports the importance of 
self-control beliefs.  She found that cancer patients who had developed a sense of 





also suggests that patients may relinquish concern over maintaining control of their health 
in late stages of cancer.  Relinquishing of control maybe perceived as a coping strategy 
because the cancer patient does not bear the burden of failing to control her disease.  
Additionally, relinquish of control may also enhance/preserve her quality of life and 
facilitate coping with the course of cancer (e.g., acceptance of death).  
Individuals who believe they can control their environment or their health often 
attempt to do so (Dabbs & Kirscht, 1971).  Lewis, Haberman, and Wallhagen (1987) 
reported cancer patients with an internal health locus of control orientation tended to 
believe that the following domains were under their control: adjustment to treatment, 
cancer, daily activities, ownership-responsibility for disease, pain, and externalizing 
control.  Caplan (1981) found individuals who attempted to cognitively control their 
health by imparting meaning or purpose to it, also created a world that was in their 
control. Taylor, Lichtman, and Wood (1984, as cited in Taylor & Armor, 1996) reported 
that asymptomatic BC patients often perceive having control over their cancer and 
believe they can prevent it from coming back. Taylor et al. (1984, as cited in Taylor et al., 
1996) also reported that many BC patients asserted having a high degree of personal 
control over their cancer (i.e., an individual can change their health status or prevent 
recurrence), despite the fact that their medical records revealed a poor prognosis.  This 
belief in personal control over cancer was positively associated with psychological 
adjustment.  These perceptions of personal control over the cancer may have served as a 
coping strategy. Furthermore, Newsom, Schultz, and Kapp (1996) posit that beliefs in 





patients.  However, these authors state that research findings have been inconclusive 
regarding the benefits of beliefs control over the course of an illness. 
 Watson, Greer, Pruyn, and Ven Den Borne (1990) reported cancer patients with 
high internal control beliefs over the course of their illness were associated with a 
positive, “fighting” attitude toward the disease.  This finding was largely confined to 
those patients with relatively good prognosis whose disease was either in remission or at 
an early stage. Additionally, Pruyn et al. (1988, as cited in Watson et al., 1990) examined 
head and neck cancer patient’s internal control over the cause of their illness and internal 
control over the course of their illness, (i.e., how their cancer will progress).  Patients 
with high internal locus of control regarding the course of their illness experienced less 
loss of control and were more likely to show health-related behavior, received more 
social support, showed higher self-esteem, experienced less physical complaints, had less 
anxiety, less depression, and less psychological and physical complaints.  In comparison, 
cancer patients with high internal locus of control regarding the cause of their illness 
reported more loss of control, suggesting that patients attributing personality 
characteristics for the cause of their cancer may have heightened levels of anxiety and 
may be preoccupied with their disease.  Furthermore, individuals with early-staged 
cancers and who believe that the course of their disease is under their control may have a 
more optimistic, fighting attitude toward the disease.  However, if the cancer progresses 
and the prognosis becomes poor, psychological well-being may become compromised for 
these same patients. 
 If psychological well-being should become compromised, it is postulated that 





1998; Ringdal, 1996). Lewis et al. (1987) examined late-stage cancer patients who 
relinquished control of their disease and reported that patients were satisfied with their 
decision.  These patients were hopeful that their “powerful others” (i.e., physicians) 
would help them gain their health back.  Similarly, Surla (1984, as cited in Lewis et al., 
1987) discovered that late-stage cancer patients, who relied on their physician’s 
management of their cancer treatment and prognosis, did not want to assume or 
participate in trying to establish control over their treatment protocol (as cited in Lewis et 
al., 1987). Thompson and Spacapan (as cited in Taylor et al., 1996), in their study of men 
with advanced stages of AIDS reported a high degree of control over their day-to-day 
medical care and treatment, but only a mild degree of control over the course of their 
illness.  Stage of disease, whether a patient is symptomatic, disease prognosis, and 
cognitive coping strategies appear to be some of the mediating factors which may 
account for differences found in cancer patients regarding health locus of control 
orientation. 
 Wagner, Armstrong, and Laughlin (1995) report contradictory findings regarding 
an internal health locus of control orientation. They investigated coping styles and quality 
of life ratings after onset of cancer in a sample of men diagnosed with different types of 
cancer.  Their findings revealed that at the time of the cancer diagnosis, the stronger a 
person’s motivation to control the effects of cancer, the poorer was the patient’s quality 
of life perception.  Also, the more motivated the patients were to control their cancer, the 
lower was their quality of life rating.  The researchers suggest that patients with greater 
levels of motivations to preserve their quality of life became more dissatisfied with 





patients who suffer a loss of personal control (i.e., cancer progresses) also may 
experience a decrement in quality of life. 
Graci (1998) investigated whether greater beliefs in internal health locus of 
control would related to lower Psychological QL in a sample of recurrent BC patients.  
For early staged and over all cancer stages, non-significant relationships were reported.   
Although, for later stages, a marginally significant negative association was found, 
possibly suggesting that as disease progresses, women with higher beliefs in internal 
locus of control will report lower Psychological QL.  Additionally, Graci reported a non-
significant relationship between greater internal control beliefs and higher Functional QL 
ratings for early stages and over all stages of cancer.  Surprisingly, a positive significant 
correlation was found for greater beliefs in internal control and Functional QL in late 
stages of cancer.  It is hypothesized that having a high internal locus of control in 
advanced cancer stages may cause a woman to experience less loss of control, be more 
likely to show health-related behavior (attend treatments or doctor appointments), 
receive more social support, and have higher self-esteem.  Additionally, internal 
orientations may cause women to experience less physical complaints, anxiety, and 
depression as well as other psychological complaints. Lastly, if psychological well-being 
is being compromised, switching health locus of control orientations may enhance 
Psychological QL.  It may be more advantageous psychologically for a recurrent BC 
patient, with a late stage cancer, to have an internal health locus of control orientation 
because it may increase her optimism and promote a “fighting” attitude toward the 





levels of Psychological QL. It is plausible that the more control a patient perceives over 
her health regardless of disease stage, psychological adjustment will be enhanced.   
 Although the research reports contradictory findings regarding quality of life and 
health locus of control beliefs, one cannot ignore the fact that control does appear to be 
an important predictor of quality of life.  Control also appears to serve as a coping 
strategy and may buffer against the deleterious effects (e.g., psychological/functional 
disability) of cancer (Friedman et al., 1992, Friedman et al., 1994; Taylor et al., 1996).  
Relinquish of disease control may be an important factor for late-stage cancer patients in 
trying to improve/restore quality of life.   
 Newsom et al. (1996) conducted a longitudinal analysis of specific domains of 
internal control and depressive symptoms in patients with recurrent cancers.  The 
researchers reported that high internal control beliefs were related to depressive 
symptomatology.  For these individuals with perceived control over cancer onset, despite 
actions to prevent progression, had greater negative affect.  However, the researchers 
found a significant decline in illness course control.  The authors postulated that in the 
early-disease stages, a sense of control over the course of cancer is associated with 
depression levels, but as the illness and symptoms progress, patients lose their sense of 
control over their illness. The theory that health locus of control beliefs fluctuate as 
cancer progresses, is an area worthy of investigation. 
Optimism 
Many individuals believe that positive thinking leads to a more enriched life and 
can aid individuals in adverse situations. When individuals are faced with adversity, they 





al., 1989).  Optimistic behavior is regarded as the continued striving of an individual who 
perceives an outcome as being attainable. This type of individual will additionally strive 
toward achieving the desired outcome even when obstacles arise (Friedman et al, 1992; 
Friedman et al., 1994; Scheier & Carver, 1992).  Conversely, pessimistic behavior is 
regarded as giving up and turning away, occurring when individuals perceive outcomes 
as unattainable. These individuals will withdraw their effort and disengage themselves 
from pursuit of the established goal/outcome. Carver et al. (1993) postulate that 
individuals who believe that their goals are attainable experience positive affect and those 
who view their goals as unattainable experience negative affect. Positive affect often 
includes enhanced psychological well-being of an individual whose emotions can range 
from pride to gratitude to simple relief.  In contrast, negative affect can encompass 
feelings of shame, anger, resentment, depression, and mood disturbance.  
Optimism is defined as the tendency to believe or the expectation that things will 
work out positively (Scheier & Carver, 1985; 1986; 1992). A fundamental disposition 
toward generally positive or negative outcomes constitutes an individual’s life 
orientation.  This life orientation construct allows for the observation of whether an 
individual’s expectation of an outcome will be good or bad, rather than internally or 
externally controlled (Knapp, 1993). Carver et al. (1993) suggest that by defining 
optimism in this mannerism, predictions can be made about an individual’s overt action 
because expectancies become a major determinant of behavior. Carver and Scheier 
(1992) have labeled Dispositional Optimism as the personality variable that affects how 
individuals cope with stressors/adversity.  Dispositional Optimism is defined as the 





life (Scheier et al., 1985).  Additionally, Dispositional Optimism is perceived as a stable 
personality trait that exists across time and context (Scheier & Carver, 1985; 1992; 
Scheier et al., 1989; Scheier, Weintraub, & Carver, 1986).  
Reker and Wong (1985) have suggested that Hope and Optimism be used as 
interchangeable constructs.  In terms of Psychological and Functional aspects of QL, 
Hope and Optimism may be of significant benefit to illness.  The general literature 
suggests that Optimism, or Dispositional Optimism, may be influential in adaptation to 
illness because it may provide some protection against illness and disease. This 
protection is hypothesized to be influenced by Dispositional Optimism, which is 
perceived as being a determinant/mediator of a person’s ability to cope with or respond to 
stress (Carver et al., 1993; Scheier & Carver, 1986).  Dispositional Optimism may act as 
a buffer against adversity and lower the psychological distress associated with the 
adversity. 
The effect of Optimism on Psychological Well-Being and over-all reported QL 
has been a topic of research interest.  Taylor et al. (1996) suggest that unrealistic 
Optimism may aid an individual in coping with a traumatic event or health-related event 
because it provides an individual with a sense of mastery over their life.  However, 
Taylor and Armor assert that once unrealistic Optimism is disconfirmed, an individual 
may experience severe psychological distress. Stanton and Snider’s study (as cited in 
Lauver & Tak, 1995) of coping and emotional outcomes of women undergoing breast 
biopsies reported that Optimism was associated with less avoidance strategies (e.g., 
wishing it would go away) and less emotional distress.  Additionally, Graci (1998) 





Optimism and higher Psychological and Functional QL ratings in a sample of recurrent 
BC patients. 
Similarly, Carver et al. (1993) studied the relationship of optimism to coping and 
emotional adjustment in a sample of BC patients undergoing cancer treatment. Carver et 
al. interviewed these patients at different time periods: one day prior to surgery, ten days, 
three months, six months, and a year postsurgery. They found optimism to be associated 
with greater levels of active planning and acceptance, and lower levels of psychological 
disengagement (e.g., denial) during initial treatment. Acceptance of breast cancer in early 
treatment was associated with less psychological distress (e.g., anxiety, depression, and 
anger) than in later treatment. Psychological and behavioral disengagement in early 
treatment was associated with greater levels of psychological distress. Additionally, 
Scheier, Carver, & Bridges (1994) investigated the relationship of optimism to emotional 
and functional outcomes of coping in BC patients undergoing cancer treatment at three 
time periods: one day prior to surgery, six-to-eight days, and six months postsurgically. 
Optimism was associated with higher ratings of quality of life prior to surgery, and at the 
six-month follow-up period. 
Scheier et al. (1989) interviewed male coronary artery bypass surgery patients 
regarding optimism, coping tactics, mood, and quality of life at three points in time: one 
day prior to surgery, six-to-eight days, and six months postsurgery.  Presurgical optimists 
reported lower levels of depression and hostility than did pessimists. This same group 
also reported making plans for their future and setting goals for their recovery more often 
than did pessimists.  Optimists also reported being less focused on the negative aspects of 





week postsurgery time period, optimists reported greater feelings of relief and happiness, 
greater satisfaction with the level of medicare received and more emotional support from 
friends than pessimists. They also were more likely to report seeking out and requesting 
information from their physician regarding the recovery process and were less likely to 
suppress thoughts about their physical symptoms than pessimists.  At the six-month 
follow-up, optimists reported higher quality of life ratings than did pessimists. The 
researchers suggest that the differences found in quality of life ratings at the six-month 
follow-up were due to the different coping strategies utilized by the patients. 
Scheier, Matthews, Owens, Magovern, and Carver (1990) in a five-year follow-up 
study from the same group of male patients in the Scheier et al. (1989) study, found that 
optimists felt more rested following sleep and were less likely to waken in the early 
morning.  Optimists also rated their lives as more interesting and diverse, and free from 
pressures and annoyances when compared to pessimists. Lastly, optimists reported 
greater employment satisfaction and reported higher quality of life ratings than 
pessimists. 
To date, no research has been conducted on comparing the effects of optimism on 
quality of life ratings of patients with an initial versus recurrent BC diagnosis.  While 
optimism has been shown to positively influence psychological QL, the prognosis of the 
disease, severity of pain, duration of the disease, and a patient’s dispositional orientation 
must be taken into account when discussing quality of life. Most researchers would agree 
that a diagnosis of breast cancer is threatening and reduces one’s hope and optimism 
about the future.  Christ (1993) suggests that a recurrent diagnosis may greatly reduce 





a recurrent BC patient may develop an overly optimistic outlook on her disease, which 
may yield psychological distress if her beliefs are shattered.  
It is plausible that with an initial BC diagnosis, psychological distress increases 
and optimism decreases.  However, with a recurrent diagnosis, psychological distress 
may increase or decrease depending on what skills, supports, knowledge, expectancies 
regarding recurrence, and coping strategies a patient has developed since the initial 
diagnosis.   Psychological distress may not be as severe as during an initial diagnosis 
because the patient has been through it once and it has become a day to day reality.  
Additionally, an increase in optimism for a recurrent patient may activate a fighting 
attitude because the patient fought the cancer the first time, they can fight it again.  
Silberfarb et al. (1980) suggest that psychological turmoil is predictable if a 
disease should progress, generally yielding a poor prognosis.  However, employing active 
coping strategies may act as a buffer against experiencing psychological turmoil 
(Friedman et al., 1992, Friedman et al., 1994; Taylor et al. 1996).  The relationship of 
optimism to coping and quality of life appears to play a pivotal role in patients with 
chronic or terminal illness (Carver et al., 1994; Carver et al., 1993; Friedman et al., 1992; 
Lauver et al., 1995; Sheier et al., 1989; 1992; Scheier et al., 1994; Scheier et al, 1986). 
Although coping style may be a salient factor in reported quality of life, it is beyond the 
scope of this study. 
The literature presents conflicting findings regarding the effect of optimism on 
chronic and terminally ill patients.  Unrealistic optimism is theorized to encourage coping 
disadvantages (Scheier et al., 1992).  For example, a person may believe that through 





example, an individual may simply sit and wait for something to happen without putting 
forth any effort to achieve the goal.  If the positive outcome does not occur, the person 
may experience emotional/psychological distress.  
The contradictory findings regarding optimism and quality of life appear to 
revolve around issues of controllability.  Optimism has been reported to be harmful in 
situations when the outcome is not achievable or alterable (Carver, 1986; Scheier et al., 
1992).  For example, if an optimist holds positive expectations or assumptions regarding 
something that is perceived as being controllable or alterable, and if these expectations 
are disconfirmed, psychological distress might result (Taylor et al., 1996).  When 
optimistic beliefs are shattered, lower quality of life may occur.  If a BC cancer patient 
believes that her cancer is getting better or does not believe she has a poor prognosis, she 
may experience severe psychological distress if the cancer spreads. In comparison, if an 
optimist views a stressor as being controllable, changeable, or alterable, then higher 
ratings of quality of life are reported. 
 In order to compensate for the psychological distress associated with the 
shattering of beliefs, a BC patient may cognitively restructure her belief system.  This 
restructuring of beliefs may take on the form of acceptance, viewing the cancer in a more 
realistic light, or positively reframing the situation (i.e., the cancer has caused me to grow 
closer to my family) (Scheier, 1994). Lastly, Taylor et al. (1996) assert that individuals, 
who experience personal tragedies or setbacks and respond with adaptive coping 
methods, report higher levels of psychological QL. 
Thompson and Pitts (1993) suggest that positively reframing a traumatic event, 





events in a positive light.  By concentrating on the positive side of a cancer experience, 
individuals may reduce the negativity associated with cancer or the pain encountered 
from the disease, producing feelings that life is still meaningful (Thompson et al., 1993).  
Thus, restructuring of beliefs may be perceived as an adaptive coping strategy, promoting 
higher ratings of quality of life. 
Conclusion 
 Health is generally reported to be a central factor in an individual’s perception of 
QL.  Although some aspects of QL may be significantly impaired during cancer 
treatment, an optimistic outlook can enhance psychological and functional quality of life.  
More specifically, optimism may act as a psychological resource that promotes health 
and lessens the effects of illness. Additionally, the general literature suggests functional 
QL may be a causal participant to optimism.  However, the literature suggests a 
bidirectional relationship between optimism and psychological QL.  That is, optimism 
and psychological QL of a BC patient are mutually independent. 
 Cancer patients have been found to be better adjusted if they perceive themselves 
to have some personal control over their life (Lewis, 1982; Taylor, 1982).  Chronic 
illness may even produce a shift toward an external locus of control over one’s life (Reid, 
1989).  Every form of cancer treatment carries with it some degree of physical and 
emotional morbidity and issues of QL become critical. QL becomes even more important 
in late stages of cancer because psychological and functional QL, as well as physical and 
social functioning, become more impaired.  The more impaired an individual becomes, 





can act as a buffer against the pain and discomfort caused by the disease, thereby 
enhancing a woman’s satisfaction with her well-being or current level of functioning. 
 Since research on recurrent cancer is still in its early exploratory stages, one can 
only speculate about the differences reported for women with an initial versus recurrent 
diagnosis in the area of QL, optimism, and health locus of control beliefs. The present 
study was designed to examine the relationship of these variables and how these variables 
affect the quality of life of patients with initial versus recurrent BC patients. 
 There were three main goals of this comparison study of women with an initial 
BC (IBC) versus recurrent BC (RBC) diagnosis. The first goal addressed how health 
locus of control beliefs and disease stage relate to QL.  The second goal examined the 
relationship between optimism and QL.  The third goal examined the relationship 
between participant’s marital status and QL. 
Hypotheses and Research Questions 
 Seven major hypotheses, with subhypotheses, as well as several research questions were 
investigated: 
     Hypothesis 1.   Psychological QL would have a negative relationship to HLOC for 
women with IBC (Goal #1). 
     Research Question 1.  Investigate the relationship between Psychological QL and 
HLOC for women with RBC (Goal #1). 
     Hypothesis 2.   Women with IBC would have lower Psychological QL than women 
with RBC, controlling for level of HLOC (Goal #1). 
     Research Question 2.  Investigated the possible statistical interaction between IBC and 





     Hypothesis 3a.  Functional QL would have a positive relationship to HLOC for 
women with IBC (Goal #1). 
     Hypothesis 3b.  Functional QL would have a negative relationship to HLOC for 
women with RBC (Goal #1). 
     Research Question 3.  Investigated the difference in Functional QL for women with 
IBC versus RBC, controlling for level of HLOC (Goal #1). 
     Research Question 4.  Investigated the possible statistical interaction between IBC and 
RBC with Functional QL and HLOC (Goal #1). 
     Hypothesis 4.   Stages I or II  BC cancers would be a significant predictor of higher 
quality of life than women classified within more advanced cancer (i.e., advancement in 
cancer stage will relate to lower QL) (Goal #1). 
     Hypothesis 5a.  Women with RBC would be more optimistic than women with IBC 
(Goal #2). 
     Hypothesis 5b.  Women with RBC would report higher Psychological QL than women 
with IBC (Goal #2). 
     Hypothesis 5c.   Women with RBC would report higher levels of Functional QL than 
women with IBC (Goal #2). 
     Hypothesis 6:  Marriage or having a significant other would be a predictor of higher 
Psychological and Functional QL than women without a significant other (i.e., having a 
significant other would relate to higher Psychological and Functional QL) (Goal #3). 
     Research Question 6a.  Investigated the relationship between Social QL and Physical 





     Research Question 6b.  Investigated the relationship between overall composite QL 
ratings and Marital Status (Goal #3). 
     Hypothesis 7:  RBC participants would report higher overall composite QL ratings 











Recurrent breast cancer participants.  Twenty-eight female participants diagnosed 
with recurrent breast cancer were recruited from doctors’ offices and/or cancer support 
groups in the Dallas-Fort Worth area. According to the National Institute of Health, the 
stage of cancer refers to the size of the tumor, the number and location of lymph nodes 
involved, and the degree of how far the cancer has spread.  Diagnosis of the stage of 
cancer falls within four ordinal categories: Stage I, Stage II, Stage III, and Stage IV.  
Stages I and II refer to early progression of cancers and Stages III and IV refer to 
advanced progression.  Individuals in Stage IV cancers are classified as terminally ill 
because the cancer has spread out to other distant sites of the body such as from the 
breast to the bones.   
 Recurrent malignancy is operationally defined in two ways: 1)  the clinical state 
in which a woman with breast cancer has successfully completed a course of treatment 
therapy, and 2) the patient has been in a period of stability (without signs and symptoms 
of cancer) for a period of at least 6-months but is then found to have further evidence of 
malignancy (Mahon et al., 1995; Rummans et al., 1998).  Criteria for inclusion are that 
the participants: (a) have recurring breast cancer; (b)  be able to speak, read, and write in 
English; (c) be able and give informed consent; (d) be able to complete a data collection 





Information on stage of cancers will be obtained directly from participants. A 
diverse group of participants were chosen to identify the range and magnitude of 
functional and psychosocial issues associated with a cancer experience.  Data collection 
was completed during an twenty-month period starting late November, 1997 to July, 
1999. 
Initial breast cancer participants. The second group of twenty-seven participants 
were chosen to be age-matched controls for the above participants with recurrent breast 
cancer.  Similar recruiting and staging methods were used for these initial breast cancer 
participants, except these participants were chosen to be first time breast cancer patients. 
Participation rates regarding completion of questionnaire. Approximately 35% of 
the initial BC participants declined participation in the current study when approached by 
either a nurse, breast cancer support group facilitator or the primary investigator of this 
study.  These group of women consistently commented that the questionnaire was too 
long or they were not interested in participating in research.  In comparison, 
approximately 100% of recurrent BC patients were agreeable to participation in the 
current study when approached.  Initial BC patients also had a consistently lower 
response rate to the open-ended questions than the recurrent BC patients. 
Design 
 This is a cross-sectional study with two major dependent variables and multiple 
independent variables. The constructs being investigated are presented in Table 1.  In this 
study, the focus is on the major dependent variable of interest, QL, consisting of two 
components: psychological and functional QL. Psychological QL represents an 





depression, denial, distress, sense of well-being and/or hope are the factors of 
psychological QL.  Functional QL represents an individual’s task-oriented ability which 
includes self-care and the physical and intellectual efforts of accomplishing things in the 
home, community and at work. 
 The independent variables of major interest are health locus of control beliefs and 
optimism.  Health locus of control refers to an individual’s belief that their health is or is 
not determined by their behavior.  Optimism refers to an individual’s expectation that 
things will work out positively. The other independent variables that are assumed to 
affect QL are patient’s age and stage of cancer.   
 Questionnaires were distributed to cancer patients via their doctor’s office or a 
cancer support group. The questionnaire was composed of several standardized measures.  
Materials 
 A demographic survey (Appendix C) was used to obtain basic information 
regarding participant’s age, ethnicity, marital status, years of education, household annual 
income, and occupational status. Due to a large percentage of participants not providing 
occupational status, social economic status was not able to be calculated.  Medical and 
treatment information was included in the demographic survey.  This information 
included stage of disease, first diagnosis, duration of remission, the type of medical 
treatment, and the duration of the treatment.  
 A modified form of the Functional Living Index-Cancer (FLIC) was used as the 
dependent measure to assess QL (Appendix C).  The original FLIC (Schipper, Clinch, 
McMurray, & Levitt, 1984) consists of 22 questions that were designed to assess overall 





FLIC and it is designed for self-administration.  It has a visual analogue scale that is 
divided into 7 equal intervals.  The numbers at the two ends of the scale (1 and 7) 
represent polar opposites.  Subjects are instructed to place a slash mark on the scoring 
line at the point that best represents their responses to questions. 
 One major modification of the original FLIC has been made for the current study. 
The M-FLIC includes a more conventional response format, requiring participants to 
respond to questions by circling the numbers that best represents their responses on a 
seven point Likert-type scale.  Wei (1993) conducted, in a sample size of ten BC patients, 
a rank-order correlation between the original FLIC and the (M-FLIC) and reported a 
correlation of .99.  Additionally, Schipper, Clinch, McMurray and Levitt (1984) 
conducted a factor analysis of the FLIC items and reported strong factor loadings of .5 
and higher. Even though the M-FLIC consists of 22 items, the scoring process will 
include only those items that loaded strongly on the psychological and functional 
domains. Furthermore in scoring the M-FLIC, two items related to chemotherapy 
treatment were not endorsed by a large percentage of participants because they had not 
undergone chemotherapy.  To make both groups equal (with chemotherapy, without 
chemotherapy), these two items were eliminated when calculating an overall QL score. 
The following psychometric data were provided by the test authors (Schipper et 
al., 1984).  The FLIC has been validated on 837 patients in two cities over a 3-year 
period.  Criteria for validity include stability of factor analysis and concurrent validation 
studies against other established measures such as the Cancer Rehabilitation Evaluation 
System (CARES). The index is also uncontaminated by social desirability issues.  





They tested the construct validity of the FLIC and reported a five-factor solution, which 
accounted for 70% of the variance and 68% in a cross-replication sample.  Convergent-
discriminant validity was also reported using independent measures of symptoms and 
anxiety. Cronbach’s alpha was reported to be in the acceptable range (i.e., .64 and higher 
for a five-factor solution). 
Optimism was assessed by the revised 13 item Life Orientation Test (LOT-R) 
designed to measure respondents’ level of optimism in terms of general outcome 
expectancies (Scheier & Carver, 1985) (Appendix C).  In the original Life Orientation 
Test (LOT) and (LOT-R), four items are fillers, which are included to obscure the central 
theme of the (LOT) and (LOT-R) (Table 2).  These items were included in the scoring 
process. In the original 8 item (LOT), half of the items were stated in a positive manner, 
and the other half were stated in a negative manner.  However, the authors of the (LOT), 
(Scheier & Carver) (1985), identified 2 problematic items: “I always look on the bright 
side of things” and “I’m a believer in the idea that every cloud has a silver lining”. These 
items were identified as mediators of optimism effects (e.g., engaging in positive 
reinterpretation and growth). Scheier et al. (1994) assert that any correlations between 
optimism, as assessed by the (LOT), and other scales/instruments measuring these 
identified mediators will be suspect because of these 2 items on the (LOT) that measure 
positive reinterpretation (e.g., looking at things in a better light) and growth.   
 The (LOT-R) eliminates these two items (when scoring), resulting in only two 
positively worded items.  In order to avoid difficulty of computing separate scores for 
positively and three negatively worded items, Scheier et al. (1994) added in one new 





positively and negatively worded items.  Scheier et al. also suggest eliminating from the 
scoring process, one of the negatively worded items (Table 2).  
Thus, items used to derive an optimism score on the (LOT-R) included only six 
items. Three items were keyed in the positive direction and three were keyed in the 
negative direction. A five point Likert-type scale ranging from “strongly agree” (scored 
as 0) to “strongly disagree” (scored as 4) was used.  After reverse scoring for the negative 
items, total scores ranged from 0 to 24, with higher scores indicating greater optimism.  
Items 1, 3, 5, 8, 12, and 13 were used to compute an overall optimism score. 
 The following psychometric data were provided by Scheier et al., 1994.  Factor 
analysis of the LOT-R supported its unidimensionality (i.e., the scale items measure a 
single underlying construct).  Cronbach’s alpha was .78 on a combined sample of 2,055 
and test-retest reliability with a sample of 187 over 28 months was .68 (4 months), .60 
(12 months), .56 (24 months), and .79 (28 months).  Additionally, the test authors tested 
the LOT-R against other measures of personality traits.  Significant positive correlations 
were reported with original (LOT) and self-esteem, as were significant negative 
correlations with trait anxiety, neuroticism, and depression, hopelessness, perceived 
stress, and social anxiety.  These findings provided support for the construct validity of 
the LOT-R. Additionally, the correlational findings between the (LOT-R) and (LOT) 
suggest the two instruments are assessing similar characteristics. 
 In order to assess the participant’s beliefs about their control over their health, 18 
items of the Multidimensional Health Locus of Control – Form C (MHLC-C) (Wallston, 
1988) was incorporated into the survey (Appendix C).  The (MHLC-C) is a disease 





(Wallston, Wallston, & DeVellis, 1978). The (MHLC-C) measures control beliefs among 
individuals having a variety of medical conditions (e.g., cancer, diabetes). It is designed 
so that the researcher can substitute a specific disease for the word condition. For 
example, “If my cancer worsens, it is my own behavior which determines how soon I feel 
better again”.  The (MHLC-C) was designed to allow optimal flexibility of investigating 
health locus of control beliefs under a variety of health conditions. 
The (MHLC-C) consists of 18 items measuring the belief of internal control over 
the onset of a disease-specific condition.  Six items assess each dimension of internal and 
chance factors and two separate 3 item subscales for the powerful others dimension The 
powerful others dimension contains items relating to doctors and other people, which is 
different from the original (MHLC, Forms A & B). Responses were offered on a six-
point Likert-type scale, ranging from “strongly disagree” (scored as 1) to “strongly 
agree” (Scored as 6).  
The following psychometric data were provided by Wallston et al. (1994).  The 
(MHLC-C) was administered to participants in an arthritis and chronic pain study. Factor 
analysis of the measure supported its unidimensionality.  Cronbach’s alpha was greater 
than .70 on a combined sample of 588 and reliably yielded a four-factor solution. 
Additionally, the test authors assessed the (MHLC-C) against another disease specific 
version of (MHLC – Forms A/B).  The subscales of the (MHLC-C) correlated 
significantly with similar subscales and did correlated significantly with dissimilar ones 
on Form B.  Wallston et al. reported that these findings demonstrate considerable 
convergent as well as discriminant validity.  The correlations between Form B and Form 






 Breast cancer patients diagnosed with both an initial and cancer recurrence were 
recruited through doctors’ offices and/or cancer support groups.  They were requested to 
participate in the study from a nurse, support group facilitator, or by the primary 
investigator of this study after having questions answered and completing the informed 
consent (Appendix C).  Each potential participant who agreed to participate in the 
research project was administered a questionnaire packet.  They were asked to read and 
keep the cover letter, including a brief introduction of the study and a request for 
participants’ assistance.  All participants were informed of the confidentiality of their 
responses.  Participants were instructed to place completed questionnaires in an envelope 
and seal it to ensure confidentiality. Approximately thirty minutes was required to 
complete each questionnaire.  If participants were not able to complete the questionnaire 
at either the doctors’ offices or support group meetings, they were provided a self-
addressed, stamped envelope to return at their convenience.   
Power 
 Since power (the probability of detecting an effect if one is present) is a concern, 
a power analysis was conducted to estimate the sample size necessary to detect an effect 
of disease stage on the relation of functional QL.  Cohen (1988) has suggested that .80 is 
a good standard for the minimum power necessary before beginning a study (as cited in 
Aiken & West, 1991).  Chang (1993) reported a significant negative correlation between 
cancer stage and QL (r = -.15).  The sample size was one hundred and five female 
participants.  Using power tables, a sample size of 85 participants should be sufficient to 





= .32, p =.05 (unidirectional) and a correlation of r = .36, p = .05 (two-tailed) should be 
detected with power of .80.  Within each subsample of approximately 30, a correlation of 






  RESULTS 
Descriptive Statistics 
Demographic and medical information.  The purpose of the study was to investigate the 
variables affecting both initial and recurrent BC patients’ quality of life. Table 3 
summarizes descriptive data for all participants and comparing IBC and RBC women on 
psychosocial measures.  The chance MHLOC subscale  was the only psychosocial 
measure to demonstrate significant differences between IBC and RBC women (t (df = 52) 
= -2.09, p = .041).  Tables 4-6 summarize the descriptive information on all the major 
variables included in the following analyses. These tables include both separate and 
combined group frequencies for IBC and RBC women.  SES could not be calculated 
because only a small number of participants included information about employment 
status.   
 One of the major descriptive findings from the following analyses was the 
negative skewness of the doctor, powerful other, MHLOC variable.  Only three people 
(5.5%) from the entire sample reported low doctor, powerful other, MHLOC (1-3) 
compared to 52 people (94.5%) who reported high doctor, powerful other, MHLOC (4-
6).  Thus, interpretations using doctor MHLOC should be made with caution since the 
majority of IBC and RBC women placed high belief in their doctors. Descriptive 
statistics, including frequencies, means, standard deviations, stem-and-leaf displays, box-
whisker plots, and skewness, kurtosis and standard error (SE) of skewness and kurtosis, 
were be performed on demographic and psychosocial information. Diagnostic statistics 





checked for the presence of outliers. There were no outliers; however, violations of 
normality assumptions were found and log transformations were attempted.  Overall, the 
transformations did not significantly change the majority of calculated results and are not 
reported. Perusal of scatterplots indicated no problems with linearity or 
heteroscadasticity. 
Table 4 illustrates combined and separate frequencies and percentages of 
demographic variables for IBC and RBC participants. The mean age of participants was 
55.02 years (SD = 11.35) years, and there was no significant difference in age for the 
RBC (X = 56.64, SD = 11.88) and IBC (X = 53.39, SD = 10.75) groups (t (df = 53.47) = 
1.07, p =.288).  There were significant differences in education for the RBC and IBC 
groups (t (df = 54) = -2.38, p = .020), with IBC women having a mean educational level 
of 4.96 (SD = 1.62) compared to 3.96 in the RBC group (SD =1.50). See Table 4 for 
descriptives and scaling.   
Participants’ marital status as shown in Table 4 demonstrates that 58.9% were 
married, 23.2% were separated or divorced, 12.5% were widowed, and 5.4% were single 
or never been married. There was a trend toward differences in marital status between 
IBC and RBC women (χ2= 6.97, df = 3, p = .073) with 57.6% of IBC women reporting 
being married compared to 42.4% of RBC women.  Most of the participants were 
Caucasian (89.3%), some were African Americans (7.1%), and some reported “other” 
ethnicity (3.6%). There were no significant differences in ethnicity for the IBC and RBC 
women (χ2 = 4.32, df = 2, p = .115). 
 The majority of women (50.0%) were employed full-time, 18.0% were employed 





working outside the home. There were significant differences in employment status for 
the IBC and RBC women (χ2 = 9.52, df = 3, p = .023). The majority of IBC women 
55.6% were employed full-time compared to 43.5% for RBC women. 
Table 5 illustrates combined and separate frequencies and percentages of medical 
demographic variables for IBC and RBC participants. The descriptive information on 
medical information shows that there were more women (n = 18) with Stage 1 (40.0%) 
than women with Stage II (28.9%), Stage III (13.3%), and Stage 4 (17.8%) cancer (χ2 = 
45, df = 3, p = .000).  The mean cancer stage of participants was 2.09 (SD = 1.12), and 
there was a significant difference in cancer stage for the RBC and IBC groups (χ2 = 
12.90, df = 3, p = .005), (t (df = 43) = 4.01, p = .000). The mean cancer stage of IBC 
participants was 1.52 (SD = .67) compared to 2.68 in the RBC group (SD =1.21).  
Approximately 56.5% of IBC women were diagnosed as stage 1 cancers compared to 
22.7% of RBC women.  Less than one-third (29.2%) of RBC women also reported 
having additional, that is more, than 2 recurrent cancer diagnoses.  
Reliability 
 Cronbach’s alpha coefficients were run for each scale in the analyses.  Results 
demonstrated that reliabilities were adequate (Table 6).  The alpha for the psychological 
subscale of the M-FLIC was 0.80.  The alpha for the functional subscale of the M-FLIC 
was 0.88.  The alpha for the psychological and functional subscales was 0.89.  
Additionally, an alpha of 0.92 was calculated for the M-FLIC. The LOT-R demonstrated 
an alpha of 0.79.  Analyses were also reported on the original LOT and demonstrated an 
alpha of 0.85.  The alpha for the MHLOC was 0.73. The alpha for the internal MHLOC 





alpha for the Chance MHLOC subscale was 0.81.  In addition, separate reliabilities were 
conducted for IBC and RBC samples (Table 6).  The reliabilities were generally 
consistent with the exception of LOT-R.  Reliabilities for RBC women were considerably 
lower than for the IBC women. 
Hypothesis Testing 
 Table 7 summarizes all statistical findings for the following hypotheses and 
research questions.  The first hypothesis tested stated that there would be a negative 
relationship between psychological QL and internal MHLOC for women with IBC. Table 
9 displays a correlation matrix between health locus of control and psychological QL for 
IBC women.  Results revealed a non-significant correlation between these two variables 
(r = 0.06, p = 0.378). Additional analyses were conducted with psychological QL and the 
other subscales of the MHLOC (the doctor and people subscales of the powerful other 
MHLOC and chance factors MHLOC); the only subscale to yield marginally significant 
results was for doctor MHLOC and psychological QL (r = 0.33, p = 0.093) (Table 8). 
 Additional analyses were conducted on the research question of whether there 
would be a relationship between psychological QL and internal MHLOC for women with 
RBC (Table 8). Obtained results showed that there was no significant relationship 
between psychological QL and three of the four MHLOC domains: internal (r = -0.006, p 
= 0.466), people (r = -0.24, p = 0.237) and chance (r = -0.02, p = 0.934). However, results 
indicated that there was a significant relationship between psychological QL and doctor 
MHLOC (r = 0.48, p = 0.011). 
 The second hypothesis tested stated that women with IBC would have lower 





there was no difference between women with IBC and RBC for psychological QL (F, (1, 
53) = 2.38, p = 0.129, R2 = .08, adj R2 = .06). However, there was a trend in the 
hypothesized direction, with IBC women reporting lower mean scores for psychological 
QL (4.67) than RBC women (5.15). Although it was initially proposed that this analysis 
would be conducted with MHLOC as a covariate, the non-significant results indicated 
that this analysis would not be appropriate. Nevertheless, additional ANCOVAs were 
conducted using each of the four subscales of the MHLOC as covariates. For the 
ANCOVA using doctor, powerful other, MHLOC as the covariate, the analysis yielded 
significant results (F, (2, 51) = 6.03, p = 0.004, R2 = .10 and adj R2 = .16) with a 
significant effect for doctor, powerful other, MHLOC (F = 10.94, p = .003). However, it 
should be noted given the severe skewness of the doctor MHLOC and the large number 
of exploratory analyses using the subscales of the MHLOC, this result should be 
interpreted with caution.  
The second research question tested stated that psychological QL would differ for 
women depending on their cancer group and MHLOC. A 2 (IBC vs. RBC group) X 2 
(internal vs. external MHLOC) ANOVA was used, testing for main effects for group and 
MHLOC, as well as interactions between the two. However, these results did not yield 
significant results (F, (3, 50) = 0.78, p = 0.513). In addition, analyses were conducted 
using the other three scales of the MHLOC; however, none of these analyses yielded 
significant results.  Initially, it was hypothesized that stage should be covaried from these 
analyses. Because of the non-significant results, however, it was determined that an 





The third set of hypotheses suggested that there would be a differential 
relationship between functional QL and internal MHLOC, depending on whether the 
woman had IBC or RBC. Specifically, it was hypothesized that women with RBC would 
have a negative relationship between functional QL and internal MHLOC and women 
with IBC would have a positive relationship between functional QL and internal 
MHLOC. However, results indicated that there was no significant relationship between 
functional QL and internal MHLOC for either RBC (r = 0.19, p = 0.177) or IBC (r = 
0.04, p = 0.431) groups (Table 9). In addition, analyses were conducted for the other 
three subscales of the MHLOC. Similar to previous analyses, a significant correlation 
was found between functional QL and doctor MHLOC for both RBC (r = 0.39, p = 
0.044) and IBC (r = 0.46, p = 0.015), but not for people MHLOC, RBC (r = 0.03, p = 
0.887) and IBC (r = 0.22, p = 0.263), or chance MHLOC, RBC (r = -0.01, p = 0.971) and 
IBC (r = 0.04, p = 0.856) (Table 9).   
The third research question tested stated that women with IBC differ on functional 
QL compared to women with RBC. Results from a one-way ANOVA indicate that there 
was no difference between women with IBC and RBC for functional QL (F, (1, 53) = 
0.77, p = 0.364). Although it was initially proposed that this analysis would be conducted 
with MHLOC as a covariate, the non-significant results indicated that this analysis would 
not be appropriate. Nevertheless, additional ANCOVAs were conducted using each of the 
four subscales of the MHLOC as covariates. For the ANCOVA using doctor MHLOC as 
the covariate, the analysis yielded significant overall results (F, (2, 51) = 6.02, p = 0.004, 
R2 = .101 and adj R2 = .159) with a significant covariate effect for doctor MHLOC (F = 





However, it should be noted given the severe skewness of the doctor MHLOC and the 
large number of exploratory analyses using the MHLOC, this result should be interpreted 
with caution. 
The fourth set of hypotheses tested suggested that women with lower stages of 
BC (stage 1 or 2), regardless of initial or recurrent status, would have higher 
psychological QL, higher functional QL, and higher overall QL ratings than women with 
advanced stages of BC (stage 3 or 4). A point biserial correlation indicated that there was 
no relationship between stage of cancer and psychological QL (r = 0.02, p = 0.446).  
However, a point biserial correlation indicated that there was a significant relationship 
between stage of cancer and functional QL (r = -0.28, p = 0.013). A point biserial 
correlation indicated that there was no relationship between stage of cancer and overall 
QL, although there was a trend toward significance, with functional QL contributing to 
overall QL trend (r = -.16, p = .093). 
The fourth research question stated that functional QL would differ for women 
depending on their cancer group and MHLOC. A 2 (IBC vs. RBC group) X 2 (internal 
vs. external MHLOC) ANOVA was used, testing for main effects for group and 
MHLOC, as well as interactions between the two. However, these results did not yield 
significant results (F, (3, 50) = 0.48, p = 0.695). In addition, analyses were conducted 
using the other three scales of the MHLOC; however, none of these analyses yielded 
significant results. Although, when the relationship between cancer stage (1-4) and 
MHLOC (internal and external) was examined, a significant relationship was found (F, 
(7, 36) = 2.55, p = 0.030, R2 = .33, adj R2 = .20), with a significant effect for stage (F 





women in stage 1 cancer (5.72). There was no significant difference between these two 
groups for functional QL compared to women with stage 2 (5.71) or stage 3 cancer 
(4.98).  
The fifth set of hypotheses stated that women with RBC would be more 
optimistic, report higher psychological QL, and higher functional QL than women with 
IBC. However, results indicated that there were no significant differences between RBC 
and IBC women for optimism (t (54) = 0.05, p = .959), psychological QL (t (52) = 1.55, p 
= .128), and functional QL (t (53) = -0.88, p = .384). However, when these analyses were 
reanalyzed using an ANCOVA, with stage of cancer as the covariate, significant results 
were obtained between IBC and RBC women for functional QL (F, (2, 42) = 5.75, p = 
0.006, R2 = .215, adj R2 = .177), with women with RBC reporting higher functional QL 
(5.634) and women with IBC reporting lower functional QL (5.002). In addition, a trend 
was found for psychological QL (F, (2, 42) = 2.82, p = 0.071, R2 = .118 and adj R2 = 
.076), with a significant main effect for group (F (1) = 5.38, p = .025) and with RBC 
women reporting higher psychological QL (5.315) and IBC women reporting a lower 
psychological QL (4.429). No significant relationship was found for optimism and type 
of diagnosis (F, (2, 42) = 0.81, p = 0.454). 
The sixth set of hypotheses stated that having a spouse or a significant other 
would be correlated with higher psychological QL and functional QL than women 
without a significant other. Results indicated that neither psychological QL (t (46) = -
0.13, p = .895) nor functional QL (t (43) = -0.06, p = .954) were affected by the presence 





The sixth research question investigated the relationship between social QL and 
functional QL and having a significant other present. Results indicated that neither social 
QL (t (41) = 1.33, p = .191) nor family QL (t (40) = -0.64, p = .528) were affected by the 
presence of a significant other, 
The final hypothesis suggested that RBC women would report higher overall 
composite QL ratings than IBC women. Results indicated that there was no significant 
difference between IBC and RBC women for composite QL ratings (t (50) = -0.37, p = 
.710). 
Qualitative Analysis 
 Twenty-three of the twenty-eight IBC participants (82.1%) responded to the first 
set of open-ended questions, which requested them to respond to how cancer impacted 
their life. The RBC participants had an equivalent response rate of 85.2% (23 of 27 
participants) to this same set of open-ended questions.  Descriptive Information referring 
to how cancer impacted participants’ life will refer only to these twenty-three IBC and 
twenty-three RBC women. 
 Table 10 illustrates IBC and RBC frequencies for the themes that emerged from 
responding to how cancer impacted participants’ life.  Only those categories that had a 
significant number of answers will be reported.  For in-depth review of qualitative 
analysis, refer to Table 10. Nearly one-third (30.4%) of IBC women reported 
psychological functioning as being impacted compared to 26.1% of RBC women.  Two 
thirds of IBC women (65.2%) reported difficulties with functional well-being compared 
30.4% of RBC women. Additionally, 13.0% of IBC women reported experiencing 





percent of IBC women reported having their outlook changed in some way as did 65.2% 
of RBC women.    
Twenty-five of the twenty-eight IBC participants (89.3%) responded to the 
second set of open-ended questions, which requested them to respond to what was the 
most significant way cancer impacted their life.  The RBC participants had a response 
rate of 92.6% (25/27 participants) to this same set of open-ended questions.  Descriptive 
Information referring to how cancer most significantly impacted participants’ life will 
refer only to these twenty-five IBC and twenty-five RBC women. 
 Table 11 illustrates IBC and RBC frequencies for the themes that emerged from 
responding to how cancer most significantly impacted participants’ life.  Only those 
categories that had a significant number of answers will be reported.  For in-depth review 
of qualitative analysis, refer to Table 11.  
Twelve percent of IBC women reported spiritually as being significantly impacted 
by their cancer experience compared to a 16.0% of RBC women. Twenty-eight percent of 
IBC women reported that their social functioning was positively impacted compared to 
none of the RBC women.  Eight percent of IBC women reported difficulties with 
functional well-being compared to 32.0% of RBC women. Eight-four percent of IBC 
women reported having a different outlook on life compared to 40.0% of RBC women.  
Eleven of the twenty-eight IBC participants (39.3%) responded to the third set of 
open-ended questions, which requested them to respond to any additional comments or 
concerns they may have. The RBC participants had a response rate of 70.0% (17/27 





to any additional comments or concerns will refer only to these eleven IBC and seventeen 
RBC women. 
 Table 12 illustrates IBC and RBC frequencies for the themes that emerged from 
this set of open-ended questions.  Only those categories that had a significant number of 
answers will be reported.  For in-depth review of qualitative analysis, refer to Table 12. 
Twenty-seven point three percent of IBC women reported their health was significantly 
impacted by cancer compared to none of the RBC women.  Seventy-two percent of IBC 
women reported medical care/research concerns compared to 41.2% of RBC women.  A 
smaller percentage (27.3%) of IBC women reported Spirituality as being important 
compared to 81.8% of RBC women. A small percentage (18.2%) of IBC women reported 
psychological functioning a concern compared to 47.1% of RBC women.  A moderate 
percentage (23.5%) of IBC women reported difficulties with functional well-being 
compared to none of the RBC women. Twenty-seven point three percent of IBC women 








The Discussion section is organized into three parts, referring to the three main 
research goals.  The first one addresses how health locus of control beliefs and initial or 
recurrent cancer diagnosis relate to QL.  The second question concerns the relationship 
between optimism and QL. Lastly, the third examines the relationship between 
participant’s marital status and QL.  
The relationship between Internal Health Locus of Control, Type of Diagnosis and 
Disease Stage on QL 
The first hypothesis that perceptions of internal HLOC would be negatively 
associated with psychological QL for women with an initial BC diagnosis was not 
supported.  In answering the first research question, exploratory analysis also revealed a 
non-significant association between psychological QL and internal HLOC for RBC 
women. De Valck and Vinck (1996) also reported a nonsignificant relation between 
health locus control orientation and quality of life in their study investigating health 
locus of control and quality of life in lung cancer patients.  There is no relation to discuss 
here so rather than evaluating a relationship that was not found, inspection of mean 
levels is more appropriate.  The mean internal HLOC levels, as illustrated in Table 3, are 
not significantly different from each other.  These levels of approximately 3.1 for both 
groups may be somewhat low levels of internality.  Even the scales creator, Wallston et 
al. (1994) did not provide data for normative samples.  
 Given that there were no significant mean differences, it is plausible that IBC and 





An individual may cope with their cancer diagnosis and treatment more effectively if 
they do not view their cancer as being controllable by any factor(s). Additionally, the 
lack of a significant relationship between internal HLOC and psychological QL may be 
an adaptive coping strategy.  If cancer is not perceived as being personally controllable, 
then a cancer diagnosis does not imply that a woman somehow failed or loss control and 
developed cancer. Therefore, the BC patient does not assume responsibility for failing to 
prevent the onset, progression or recurrence of cancer. The BC patient also does not 
assume responsibility for the pain, life disruption, progression of the disease, and/or the 
possibility of death. Both IBC and RBC women can cope better with their diagnosis and 
treatment, and focus on the outcome (i.e., health and longevity) without rationalizing 
why it happened to her and what she could have done to prevent it.  By removing the 
control element, the BC patient can see it as a medical event and not, for example, bad 
karma, God’s punishment, or due to some personal, psychological characteristic.   
The saliency of making a distinction between perceptions of controlling one’s 
general health versus controlling a life threatening disease such as cancer must be noted. 
The MHLC-C is a disease specific locus of control scale for cancer; BC patients may 
hold different locus of control beliefs about their cancer than they would about their 
general health status. One can see the mental health advantages for cancer patients who 
maintain different health locus of control beliefs regarding their cancer, general health, 
and overall life events (e.g., quitting smoking). Assigning control to the onset of cancer 
and control over the course of cancer is giving an individual the ability to change their 





orientation could lead to psychological distress, especially if the cancer 
progressed/reoccurred. 
General perceptions about control over general health and other life events also 
may play a role in cancer adjustment.  Perhaps BC patients do not view their cancer as 
being personally controllable but general health or other life events (e.g., ability to obtain 
an MBA, quitting smoking, etc.) are perceived as being personally controllable. Women 
may believe that by exercising and eating properly they can prolong their longevity and 
increase health, which is different from fighting off a disease like cancer.   
No studies have investigated health locus of control beliefs in patients before they 
are informed of a cancer diagnosis.  It may be that a shift in health locus of control 
beliefs occurs after communication of a cancer diagnosis.  Establishing a baseline 
measure of health locus of control orientation prior to communication of a cancer 
diagnosis and then re-testing may provide valuable information as to whether or not 
health locus of control beliefs shift/fluctuate over time.  Furthermore, the way in which a 
doctor informs BC patients about a cancer diagnosis may also interact with their health 
locus of control beliefs.  If cancer education and alternative treatment(s) are not provided 
to the BC patient, she may feel that her cancer is not personally controllable and shift her 
health locus of control beliefs to a high doctor-health locus of control orientation.  A 
sense of control that patients assign to their illness may be a key to understanding their 
psychological adjustment. 
While an internal HLOC relationship was not established with psychological QL, 
exploratory analyses revealed a positive, significant relationship between doctor HLOC 





between doctor HLOC and psychological QL for RBC women.  Western philosophy still 
influences the perception individuals have regarding the relationship between their 
health, disease, and medicine.  Many individuals maintain the belief that physicians are 
responsible for treatment of diseases like cancer and regard their own contribution to 
staying “disease free” as of trivial importance. A vast majority of the women in this 
study (94.5%) reported high HLOC belief in their doctor’s ability to treat/cure them. 
This may be more a need to believe in the physician when someone is seriously ill.   
Having a doctor HLOC may be psychosocially advantageous for a BC patient.  If 
the cancer is to progress or reoccur, the BC patient will not view it as a fault of her own, 
rather a failure in medicine to control the disease. Since a minimal number of women 
(5.5%) in this study did not believe their physician was an effective agent of treatment 
suggests losing faith in a physician has a marked effect on psychological well-being. 
The implications for a BC patient to have a doctor HLOC orientation are that 
physicians have an increased burden of maintaining BC patients’ psychological QL.  The 
saliency of establishing rapport and educating patient’s about BC, its treatment 
(including alternative ones), and what to expect in terms of life after the cancer 
experience become increasingly important. Physicians need to be empathetic when 
providing a diagnosis and be patient and understanding of the questions asked and the 
fears that a cancer patient might possess. The patient should be educated about how 
cancer will affect them psychosocially, that is how psychological (e.g., depression and 
anger), functional (e.g., fatigue, role dysfunction), social (e.g., decrement in social 
activities), and physical (e.g., hair loss, pain, vomiting) QL will be affected. Doctors 





and/or support groups so that BC patients can vent out their fears and anger, learn ways 
to decrease familial stress, increase their understanding of cancer the experience, and to 
learn adaptive coping methods.    
The MHLC-C has a four factor scale to it, that is internal, external (fate, chance, 
and powerful others – doctor and people).  This instrument does not assess spirituality in 
any manner.  Interestingly, qualitative analyses revealed that a large percentage of 
women mentioned the importance of spirituality.  Many women reported that “having 
faith in God” has helped them through their cancer experience.  Faith in God may 
increase coping.  It appears that many women have an external orientation regarding 
their health.  Comments, such as “God will take care of me” and “God will get me 
through this ordeal” makes one speculate that there may be an external, spirituality 
HLOC factor that is not measured on the MHLC-C. Using a HLOC measure that has a 
spirituality factor as one of its subscales is an area worthy of investigation. 
Furthermore, a significant difference between IBC and RBC women for 
Psychological QL was not established. It was initially hypothesized that women with 
IBC would have a lower psychological QL than RBC women, after controlling for health 
locus of control. It is plausible that a cancer diagnosis, regardless of initial or recurrent 
group status, is equally devastating and distressing to both IBC and RBC women.  
Women with an initial BC diagnosis have to experience the initial shock of receiving a 
diagnosis, as well as experience the fears associated with cancer.  These fears can 
include uncertainty of the future, uncertainty of what to expect from treatment including 
side-effects and long-term effects of cancer, as well as realizing their mortality.  These 





have knowledge regarding what to expect from the cancer experience, their mortality is 
threatened again and prognosis is generally not favorable.  Additionally, recurrent 
cancers are generally more aggressive and treatment is more intensive (toxic) than an 
initial cancer. RBC women may experience the same anxieties IBC women experience, 
for example, fear of death and uncertainty of the future.   
 It was hypothesized that early cancers (Stage I or II) would be a significant 
predictor of higher psychological QL than advanced cancers (Stage III or IV). This 
hypothesis was not supported. It is plausible that although advanced cancers have a poor 
prognosis, BC patients (regardless of type of diagnosis) may have established adequate 
coping mechanisms early on during their diagnosis.  It is also plausible that both IBC 
and RBC patients experience similar degrees of psychological distress during diagnosis, 
treatment, and post-treatment.  Additionally, valued life activities may positively 
influence psychological functioning.  If advanced staged BC patients are still engaging in 
valued life activities, this engagement might act as a buffer against the psychological 
distress associated with cancer progression.  While social, physical and functional 
abilities may have declined, they are still able to enjoy activities that are satisfying to 
them. 
Furthermore, the hypothesis that early staged cancers would predict higher overall 
QL ratings than advanced cancers was not supported.  A marginally significant relation 
was found between women with early staged cancers reporting higher overall QL than 
women with advanced staged cancers; however, functional QL contributed toward this 
trend.  These results suggest that overall QL ratings for both IBC and RBC may not be 





women in similar ways, therefore no overall relationship in QL is noted.  Researchers 
hypothesize that recurrent BC patients experience greater levels of distress than initial 
BC patients because a recurrent diagnosis is generally more life threatening than an 
initial BC diagnosis (Worden, 1989).  However, RBC women may have feared/expected 
a recurrent diagnosis and when diagnosed, these women did not experience more distress 
than IBC women. Qualitative analysis revealed that RBC women reported experiencing 
a sense of relief when diagnosed because their “greatest fear had come true”.  It is 
plausible that fears of recurrence can actually be more psychologically distressing than 
receiving a RBC diagnosis. A recurrent diagnosis may actually produce a sense of relief 
in RBC women because their greatest fear has come true and their attention can now 
focus again on surviving the cancer.  Their prior cancer experience can actually serve as 
a buffer against psychological distress because not only are they familiar with treatment 
and side-effects, but RBC women survived their first bout with cancer. Additionally, 
RBC women may have developed strong social support systems and these systems may 
act as a buffer against any functional limitations experienced by more aggressive 
therapies or progression of cancer.  Thus, both IBC and RBC women may have endorsed 
similar overall QL ratings because the impact of a cancer diagnosis and treatment is 
similar in both groups of women in terms of treatment related side-effects and social, 
psychological, and functional QL. 
It was initially hypothesized that women with IBC would have a positive 
relationship between internal HLOC and functional QL while women with RBC would 
have a negative relationship between these two variables.  These hypotheses were not 





that was not found, inspection of mean levels is more appropriate. The mean internal 
HLOC levels, as illustrated in Table 3, are not significantly different from each other.  
These levels of approximately 3.1 for both groups may be somewhat low levels of 
internality.  
Given that there were no significant mean differences, it is plausible that BC 
patients may not view their cancer as controllable. This lack of association between 
internal HLOC orientation and functional QL may be an adaptive coping mechanism.  
The side-effects of active treatment can negatively affect a BC patient’s daily routine and 
ability to self-care.  An internal HLOC orientation may not be psychologically 
advantageous to a woman who is losing her ability to self-care. Having a loss of role 
functioning can be an extremely distressing event and may render an individual to feel 
and act helpless.  In addition to the distress caused by loss of role functioning, an 
individual with an internal orientation may experience even more distress because health 
is viewed as being something that is controllable. BC patients, who do not have an 
internal HLOC orientation, are more likely to receive social support and assistance from 
others because they do not view their cancer as controllable and realize the need for 
assistance with functional abilities.  
While relation between internal HLOC and functional QL was not significant, 
exploratory analyses revealed only the doctor subscale had a significant association with 
functional QL for both IBC and RBC women.  Similar to the prior discussion regarding 
the relationship between doctor HLOC and psychological QL, it is evident that a 
physician plays an integral role in influencing the functional QL of a BC patient.  





might be experienced from cancer treatment. This education will decrease the fears 
associated with having to depend on others and it will enhance BC patients’ compliance 
of asking others to assist them.  Therefore, by educating BC patients regarding functional 
loss, patients can plan ahead by scheduling a cleaning service and/or someone to provide 
food or transportation. Patients may also opt to work from their home instead of at the 
office in order to avoid employment disruption.  Physician’s can encourage patients to 
engage in valued life activities so that functional loss is not as distressing.   
When internal HLOC was covaried, there was still no significant difference 
between IBC and RBC for functional QL.  Typically, IBC women receive less toxic, 
aggressive cancer treatment than RBC women.  Even though treatment may be more 
aggressive for RBC women and they may experience greater functional limitations than 
IBC women, RBC women may have established prior social support systems from their 
first bout with cancer.  As a result of these established social support relations, RBC 
women may not report a decrement in functional QL because of the functional assistance 
received from their social support systems.  Additionally, the saliency of valued life 
activities emerges again, acting as a buffer against the distress associated with functional 
limitations/disabilities.  It is also plausible that RBC women have already learned to 
cope/adjust with functional limitations, discomfort, and pain associated with their initial 
cancer experience.  These established coping mechanisms help buffer the distress 
associated with a recurrent diagnosis. 
It was hypothesized that early cancers (Stage I or II) would be a significant 
predictor of higher functional QL than advanced cancers (Stage III or IV).  The 





percentages of functional limitations than early staged cancer patients due to receiving 
more aggressive therapies.  These type of therapy modalities may produce a significant 
decline in functional abilities, including ability to self-care and the ability to engage in 
valued life activities. Advanced cancer patients also have a poorer prognosis and may 
have greater functional limitations (e.g., loss of mobility, pain) compared to early staged 
BC patients.  It is also hypothesized that advanced cancer patients are most likely not 
working full-time and this loss of role functioning may reduce their functional QL.  
Lastly, the relationship between psychological and functional QL and type of 
diagnosis (initial vs recurrent) was explored.  No significant difference was found 
between type of diagnosis and psychological QL. Additionally, there was a trend toward 
significance in the expected direction between RBC women having higher psychological 
QL than IBC women when stage was covaried. An initial diagnosis may be just as 
distressing as receiving a recurrent diagnosis because there is uncertainty, fear of the 
unknown, and other equally distressing stimuli affecting both groups.  Furthermore, RBC 
women may be more receptive to receiving assistance from others, have more social 
support systems to assist them, and/or engage in more value life activities. Having been 
through cancer previously, it is not as devastating because they endured treatment 
previously and survived their cancer.  RBC women may also have established adaptive 
coping mechanisms to aid them in deleterious circumstances such as the cancer 
experience and established a solid, social support system. In contrast, IBC women may 
not have developed an extensive social network, as did the RBC patient.  It is plausible 
that friends and close family members of IBC patients may not know how to cope with 





be hesitant on revealing to others her cancer diagnosis for fear of rejection or being pitied 
by others.  Either way, the IBC patient puts herself in a psychology vulnerable position, 
which may result in increase psychological distress.  Lastly, RBC families have prior 
experience with cancer, whereas IBC families do not have this same experience.  
Qualitative analysis revealed that a larger percentage of IBC participants stated that their 
cancer diagnosis has created stress within the family above and beyond the stress 
associated with the cancer experience. 
No significant difference was found between type of diagnosis and functional QL. 
However when stage was covaried, a significant difference emerged for type of 
diagnosis and functional QL.  RBC women reported higher functional QL than IBC 
women. RBC women may be more receptive to receiving assistance from others, have 
more social support systems to assist them, and/or engage in more value life activities 
than IBC women.  This finding also suggests that RBC women may anticipate a decline 
in functional abilities and do not try to engage in activities that they are not able to 
accomplish.  Lastly, the RBC women has had a prior experience(s) with cancer and its 
treatment, and is more knowledgeable in the functional limitations imposed by the 
disease and has learned to cope with the functional loss more adaptively. 
The relationship between Optimism and QL 
Initially it was hypothesized that RBC women would report greater optimism than 
IBC women.  This hypothesis was not supported.  No significant differences existed 
between IBC and RBC women.  As reported in the literature review, optimism may act as 
a buffer against adversity and lower the psychological distress associated with adversity 





for the first time, RBC patients also have to confront a recurrent adversity to their health.  
IBC patients, as well as RBC patients have their mortality threatened.  Initial BC 
diagnoses have a better prognosis than recurrent cancers.  An IBC patient may be 
optimistic about confronting the adversity because the majority of cancer diagnoses in 
this sample were in the early stages.  In a similar vein, the RBC patient is confronting her 
mortality once again.  Her optimistic strategy might be that since she “fought the cancer 
the first time, she’ll beat it this time”.  One may see the advantageous of a high doctor-
HLOC orientation in this situation.  Women can maintain their optimism because their 
health is in the care of their physician. While RBC women may be optimistic, this level 
of optimism is not distinctly different from IBC women.   
It is plausible that while optimism may positively impact QL, a BC patient may 
experience shattered beliefs if her cancer is to reoccur/progress.  A decrement in 
optimism may occur because she became overly optimistic that the cancer would not 
reoccur. While still maintaining an optimistic orientation, her beliefs can be restructured 
reflecting a more realistic view of cancer and acceptance of the cancer.  She may even 
positively reframe the situation, such as creating the belief that cancer has caused her to 
take time to experience things she has not experienced.  One RBC patient wrote, “My 
cancer has caused me to live life fuller, become more positive, grow closer to my family, 
and enrich my relationship with God.”   
The relationship between Marital Status, and QL 
Initially, it was hypothesized that women who were married or having a 
significant other would report higher psychological and functional QL ratings.  These 





is distressing at all levels and may be just as distressing to a marriage or significant 
relationship as it is to someone who is single.  
The social support theory that marriage or having a significant other can buffer 
stressful situations may not always be adaptive. For instance, the cancer experience may 
negatively impact a husband and wife.  It may affect the communications between two 
individuals, as well as affect the intimacy shared. One woman wrote, “While I am 
thankful of the cancer because it has brought me closer to God, it has destroyed my 
family.  The loss of my right breast was more than my husband could bear.  I find myself 
abandoned, being a single mother, and having to raise two small children.”   
On the other hand, it is plausible that women who are separated, divorced, or 
widowed have strong social support systems, equaling the psychological and functional 
support received from a husband or significant other. These women may also need to rely 
on others more for functional assistance; however, this may not be different from a 
woman having a significant other. Furthermore, qualitative analysis revealed that many 
women reported the importance of attending support groups to vent their anger and share 
their emotions, fears, and concerns regarding the IBC or RBC experience.  Attending a 
support group might be psychologically advantageous for both single women and women 
in significant relationships because they receive a type of support and cancer education 
not available from family, friends, and health care professionals. 
Exploratory analyses revealed that neither social QL, family QL or overall QL 
ratings were affected by the presence of a significant other.  Women without a significant 
other may have established strong social support systems which equal the social support 





overall QL.  Qualitative analysis revealed that a BC patient’s appreciation for life, 
friends, and family increased due to the cancer experience.  These women also reported 
an increased sense of renewal since they were faced with their mortality.  Many BC 
women reported wanting to spend more time with loved ones and thanking people more 
for their love and support.  This appreciation for life, or sense of renewal, may have 
increase a BC patient’s social support network which provides them with the necessary 
psychological, functional and overall quality of life needs. While a patient may suffer 
from cancer treatment or disease progression, having a new perspective on life may 
buffer the deleterious effects of cancer.  One woman wrote, “While my cancer may beat 
me, it will never take my life.  I take time now to smell the flowers and enjoy life”.   
Limitations 
One of the major limiting factors of this study was the difficulty of collecting data 
from these participants.  Over one-third of the initial breast cancer patients declined 
participation in the current study when approached by either a nurse, breast cancer 
support facilitator or the primary investigator.  These participants commented that the 
measure was either too long or they were not interested in participating in research.  
Measuring psychosocial differences between those who participate and those who decline 
would have been interesting.  Furthermore, the initial breast cancer patients who did 
participate had a consistently lower response rate to open-ended questions than the 
recurrent patients breast cancer patients.   
Information regarding how many women were recruited from doctors’ offices 
versus support groups is not known, it is plausible that women attending support groups 





majority of women were not able to include information on stage of cancer because many 
of their physician’s did not inform them of the stage or grade of tumor.  Calculations 
were run on the small sample size of women reporting stage; however, these findings 
have limited generalizability regarding psychosocial functioning and cancer stage. 
Although all attempts were made at collecting an ethnically diverse population, 
the sample was predominately Caucasian.  One can only speculate about how ethnically 
diverse women will differ on psychosocial measures.  For instance, the literature presents 
differences in optimism for different ethnicities.  African Americans tend to be more 
fatalistic/pessimistic regarding cancer diagnoses than Caucasians (Hoffman-Goetz, 
1999).  Future research is directed in obtaining a more diverse sample and investigating 
differences in quality of life, optimism, and health locus of control based on ethnicity as 
well as type of diagnosis. 
Establishing SES was not possible because the majority of participants did not 
provide information regarding their occupations, which was necessary for calculating 
SES.  Differences in SES regarding psychological and functional QL domains would 
have been interesting to explore.  Future research should focus on gathering SES 
information and determining if SES status impacts quality of life, optimism, and health 
locus of control.  
Lastly, evaluating differences in spirituality between IBC and RBC women was 
not performed.  Due to the length of the questionnaire, spirituality questions were not 
included.  Future research should investigate how IBC and RBC women differ on 
spirituality measures as well as quality of life. 





 The evidence from the present study, though not conclusive, suggests that certain 
differences do exist between IBC and RBC groups between optimism, health locus of 
control, and quality of life and that these variables can significantly influence patient’s 
general sense of well-being.  The major limitations of this study, as discussed in the prior 
section were the small sample size, lack of an ethnically diverse population, and that the 
majority of participants were not able to include information on stage of cancer.  The next 
logical step would be to increase the sample size, obtain an ethnically diverse population, 
and obtain information on stage prior to completing the survey.  In the current study, 
many participants were not informed of the stage of their cancer, but they were aware of 
how many lymph nodes were involved and the size of the tumor.  From this information, 
stage of cancer can be determined and the hypotheses can empirically tested again. 
 Significant implications arise for physicians treating BC patients.  Physicians may 
not necessarily focus entirely on a curative approach, which may reduce functional well-
being as well as psychological functioning.  Instead, physicians can combine a palliative 
approach with a curative one, that is focusing on keeping a patient comfortable and 
eliminating their pain so that they can participate in valued life activities and engage in 
more social activities.   
In the future quality of life research, development of subscales for each of the four 
QL dimensions, in addition to a global measure like the M-FLIC, will be beneficial in 
investigating an overall quality of life score to each dimension.  Obtaining participants 
within one to two weeks after being informed of an initial or recurrent diagnosis would 
be useful and may provide a more accurate measure of quality of life, optimism, and 





significant information regarding hypotheses that health locus of control orientation and 
optimism scores fluctuate over time. It is also important to assess control beliefs of BC 
patients in order to identify high risk patients who need psychological support.  Lastly, 
examining patients’ general perceptions of control as well as cancer-related control 
beliefs will increase our understanding of how BC patients adjust to their disease. 
There also have been no studies that have investigated HLOC beliefs in cancer 
patients before they are informed of a diagnosis (De Valck et al., 1996).  Further research 
is needed to verify whether patients who hold internal HLOC beliefs before they are 
aware of a cancer diagnosis differ in the informational needs from patients with an 
external HLOC orientation.  For example, De Valck reported that patients with high 
internal HLOC orientations are more aware of bodily changes and may report more 
symptoms or treatment side-effects compared to individuals with external orientations.   
High internal patients may benefit more from stress-reducing self-control techniques, like 
relaxation, than more externally oriented control beliefs.  Additionally, the original 
MHLC appears to assess somewhat distinct domains of health locus of control beliefs.  
By administering both a general health locus measure and a cancer specific measure to a 
BC population will aid researchers in exploring if BC women regard health and cancer as 
distinct entities that are or are not controllable. 
Including a spiritual dimension to the MHLC-C subscale or using an existing 
HLOC measure which includes a spirituality subscale would be an area worthy of 
investigation since a large percentage of both initial and recurrent breast cancer patient 
endorsed faith in God as controlling their life/health.  Future research needs to explore 





Finally, in terms of clinical implications, the study has provided further evidence 
that both initial and recurrent BC patients have psychosocial needs that should be 
attended to.  This study is the first to investigate some of the quality of life dimensions.  
While a person may report adequate quality of life ratings in the psychological 
dimension, an individual may report lower ratings in the functional dimensions.  A total 
QL score may not reflect such differences.  By separating out the QL dimensions and 
analyzing them, a more effective treatment plan can be implemented to aid the 










Constructs That are Being Investigated in this Study. 
             
  
CONSTRUCT       MEASURE 
             
 
  
--  Health Locus of Control  -- MHLOC-C scale (18 items) 
 
    Internal HLOC subscale 
                                                                                    Powerful Others HLOC subscale 




--Quality of Life  --M-FLIC (22 items) 
 
           Functional QL     FLIC – Functional items 
  




--Optimism                                                    --LOT-R  
(13 items but only 6 are scored) 
 
 






Items Composing the Revised Life Orientation Test (LOT-R) 
 
1. In uncertain times, I usually expect the best. 
2. It’s easy for me to relax. [Filler Item] 
3. If something can go wrong for me, it will. 
4. I always look on the bright side of things. [Not Scored] – [Positive Worded 
Item] 
5. I’m always optimistic about my future. 
6. I enjoy my friends a lot. [Filler Item] 
7. It’s important for me to keep busy. [Filler Item] 
8. I hardly ever expect things to go my way. 
9. Things never work out the way I want them to. [Not Scored] – [Negative 
Worded Item] 
10. I don’t get upset too easily. [Filler Item] 
11. I’m a believer in the idea that “every cloud has a silver lining.”  [Not Scored] – 
[Positive Worded Item] 
12. I rarely count on good things happening to me. 














































































































































































































































































































































































































































































































Table  4 
 
Frequencies and Percentages of Demographic Variables and Separated by All  
 
Participants for IBC and RBC. 
 
             




 All Subject             IBC                RBC  
Eighth Grade (1)  1        1.8         0        0.0        1        3.6 
High School Degree (2) 11     19.6          3      10.7        8      28.6 
Trade School (3)  0        0.0           0        0.0        0        0.0 
Some College(4) 21     37.5           8      28.6      13      46.4 
College Degree (5)  8      14.3          6      21.4        2        7.1 
Some Graduate/Professional Experience (6)  9      16.1           6      21.4        3      10.7 
Graduate/Professional Degree (7)                          6     10.7            5      17.9        1           3 




 All Subject             IBC                RBC  
Married 33     58.9       19     67.9       14    50.0 
Separated/Divorced 13     23.2   4     14.3         9     32.1 
Widowed   7     12.5        2     17.1         5     17.9 
Single/Never Married                                             3       5.4            3     10.7         0       0.0 
Total                                       21   100.0         28   100.0       28   100.0 
Ethnicity 
 All Subject             IBC                RBC  
Caucasian 50      89.3     27     96.4        23    82.1 
African American   4        7.1           0       0.0          4    14.3 
Other   2        3.6           1       3.6          1      3.6 




 All Subject             IBC                RBC  
Currently Employed Full-Time  25     44.6          15     53.6       10    35.7 
Currently Employed Part-Time 9      16.1           7      25.0   2      7.1 
Currently Not Working Due To Illness  6     10.7      0       0.0       6    21.4 
Currently Not Working Outside The Home         10     17.9          5     17.9   5    17.9 
Missing Data  6  10.7         1       3.6    5  17.9 




Table  5 
 
Frequencies and Percentages of Medical Demographic Variables and Separated by All 
 
Participants for IBC and RBC. 
 
             




        
 All Subject             IBC                RBC  
Stage I 18      32.1         13    46.4         5    17.9        
Stage II 13      23.2   8     28.6         5    17.9 
Stage III       6   10.7       2   7.1         4    14.3 
Stage IV  8      14.3           0     0.0       8    28.6 
Missing Data   11     19.6   5   17.9       6    21.4 
Total  56 100.0      28  100.0        28  100.0 
 
Treatment Received During First Diagnosis 
 
 All Subject             IBC                RBC 
Surgery 13      26.8     6     28.5     7  28.0 
Chemotherapy 1        1.8           1      3.6      0   0.0 
Surgery and Chemotherapy  10      17.9    2   7.1     8    28.6 
Surgery, Chemotherapy and Radiation                11      21.4          5   21.5         6    21.4 
Surgery and Radiation 16      28.6         10  35.7       6    21.4 
Surgery, Chemotherapy, Radiation, and  
Bone Marrow Transplant   1        1.8          1       3.6         0       0.0 
Missing Data                                                           1        1.8        1     3.6        1    3.6 
Total 56    100.0         28   100.0       28   100.0 
 
 
Treatment Received During Recurrent Diagnosis 
 
      RBC        
Surgery   7     12.5 
Chemotherapy  1       1.8 
Radiation  2       3.6 
Surgery and Chemotherapy  8     14.3 
Surgery, Chemotherapy and Radiation  3       5.4 
Surgery and Radiation   4       7.1 
Tamoxifen  1       3.7 
Chemotherapy and Radiation   1       1.8 
Missing Data      1       1.8      






Reliabilities for M-FLIC, LOT-R, LOT, and HLOC Scales, Including Separate  
 
Reliabilities for IBC and RBC Groups. 
 
 
        Alpha Value    
 
       All Subjects   IBC RBC   
 
M-FLIC 0.92  0.92  0.93 
 Psychological subscale 0.80  0.84  0.73 
 Functional subscale 0.88  0.86  0.90   
 Functional and Psychological subscale 0.89  0.92  0.86     
  
 
LOT-R 0.79  0.90  0.46 
LOT  0.85  0.93  0.60     
 
 
MHLOC-C 0.73  0.67  0.77 
 Internal subscale 0.69  0.74  0.62 
 Powerful Others subscale 0.68  0.73  0.62 
 Chance subscale 0.81  0.81  0.80 





 Table 7 
 
Summary of All Hypotheses, Research Questions and Statistical Values   
             
Hypotheses       Statistical  
        Values     
 
H1.  Greater internal HLOC will relate to      
lower Psychological QL for IBC women 
 
Internal-HLOC    r = .063, p = 0.378      Hypothesis not supported 
 
Exploratory analyses on additional HLOC variables 
   Doctor-HLOC r = .329, p = 0.093   Marginally significant 
   Chance-HLOC r = .060, p = 0.767    Non-significant relation  
   People-HLOC r = .072, p = 0.720   Non-significant relation 
 
RQ1. Investigate the relation between Psychological QL 
 and HLOC for RBC women. 
 
Internal-HLOC    r = -0.006, p = 0.466 Non-significant relation  
Doctor-HLOC r = .481, p = 0.011   Significant relationship 
   Chance-HLOC r = -.017, p = 0.934     Non-significant relation  
   People-HLOC r = -.236, p = 0.237   Non-significant relation 
 
H2. Women with IBC will have lower Psychological QL  
than RBC women, controlling for level of HLOC. 
 
   F, (1,53) = 2.38, p = .129              Hypothesis not supported 
    Non-significant results 
 
Trend in the hypothesized direction, with IBC women 
reporting lower mean scores for Psychological QL (4.67) 
than RBC women (5.15). 
 
RQ2. Investigate the possible statistical interaction between  
group (IBC, RBC) and HLOC (internal, external) with Psychological QL. 
 
   F, (3,50) = 0.78, p = .513    Non-significant results 
 
H3a. RBC women would have a negative relationship between  
Functional QL and Internal HLOC. 
 
Internal-HLOC    r = 0.186, p = 0.177     Hypothesis not supported  
 
Exploratory analyses on additional HLOC variables 
Doctor-HLOC r = .390, p = 0.044  Significant relationship 
   Chance-HLOC r = -.008, p = 0.971     Non-significant relation  









Table 7 (continued) 
 
 
H3b. IBC women would have a positive relationship between  
Functional QL and Internal HLOC. 
 
Internal-HLOC    r = 0.035, p = 0.431      Hypothesis not supported 
Non-significant relation 
Exploratory analyses on additional HLOC variables 
Doctor-HLOC r = .464, p = 0.015   Significant relationship 
   Chance-HLOC r = .037, p = 0.856     Non-significant relation  
   People-HLOC r = .223, p = 0.263   Non-significant relation 
 
 
RQ3. IBC women differ on Functional QL compared to RBC women, 
  controlling for level of HLOC. 
 
     F, (1,53) = 0.770, p = .364   Non-significant results 
 
H4a. Advancement in cancer stage, regardless of initial or recurrent 
diagnosis, will relate to lower Psychological QL than women with  
early stages of BC (1 or 2). 
 
   r  = 0.017, p = 0.446             Hypothesis not supported 
Non-significant relation 
          
H4b.  Advancement in cancer stage, regardless of initial or recurrent diagnosis  
will relate to lower Functional QL than women with early stages of BC (1 or 2). 
 
r  = -0.283, p = 0.013   Significant relationship  
 
 
H4c. Advancement in cancer stage, regardless of initial or recurrent 
diagnosis, will relate to lower overall QL ratings than women with  
early stages of BC (1 or 2). 
 
   r  = -0.157, p = 0.093   Marginally significant 
         
 
RQ4. Investigate the possible statistical interaction between  
group (IBC, RBC) and HLOC (internal, external) with Functional QL.  
 
F, (3,50) = 0.484, p = 0.695   Non-significant results 
 
H5a. RBC women will be more optimistic than IBC women. 
 
    t (54) = 0.051, p = .959           Non-significant results 
 
H5b. RBC women will be report higher Psychological QL than IBC women. 
 







Table 7 (continued) 
 
H5c. RBC women will be report higher levels of Functional QL than IBC women. 
 
    t (53) = -0.878, p = .384           Non-significant results 
 
H5a-c.  Hypotheses reanalyzed utilizing ANCOVA, with stage of cancer as covariate 
 
RBC women will be more optimistic than IBC women. 
 
  F, (2,42) = 0.805, p = 0.454   Non-significant results 
 
RBC women will be report higher Psychological QL than IBC women. 
 
F, (2,42) = 2.817, p = 0.071          Marginally significant 
           
RBC women will be report higher levels of Functional QL than IBC women. 
 
F, (2,42) = 5.746, p = 0.006          Significant Difference 
 
RBC reported higher Functional QL (5.634) and  
IBC women reporting lower Functional QL (5.002) 
 
 
H6a. Having a spouse or significant other would be correlated with higher  
Psychological QL than women without a significant other. 
 
   t (46) = -0133, p = .895           Hypothesis not supported 
  Non-significant results 
 
H6b. Having a spouse or significant other would be correlated with higher  
Functional QL than women without a significant other. 
 
t (43) = -0.058, p = .954          Hypothesis not supported  
  Non-significant results  
 
 
RQ6a. Investigate the relationship between Social QL and Family QL 
and having a significant other. 
 
Social QL  t (41) = 1.331, p = .191    Non-significant results  
 
Family QL t (40) = -0.637, p = .528    Non-significant results 
        
H7. RBC women would report higher overall composite QL 
ratings than IBC women. 
 
t (50) = -0.374, p = .710          Hypothesis not supported  





Table  8 
 
Correlation Matrix between Health Locus of Control and  Psychological QL  
 

















Correlation --------  -.006 .009 .481(**) -.236 -.017PSYCH  
QL 
Sig. (2-tailed) . .466 .966 .011 .237 .934
Pearson 
Correlation .063 -------- .504(**) .307 .574(**) -.030INT. 
MHLOC Sig. (1-tailed) IBC 
Sig. (2-tailed) RBC .378 . .003 .056 .001 .440
Pearson 
Correlation .170 -.048 ------------ .561(**) .763(**) .349POWER 
MHLOC 
Sig. (2-tailed) .199 .813 . .002 .000 .474
Pearson 
Correlation .329 -.132 .713(**) --------- .038 .275DOC  
MHLOC 
Sig. (2-tailed) .047(*) .511 .000 . .850 .165
Pearson 
Correlation .072 .197 .893(**) .479(*) ------------ .031PEOPLE 
MHLOC 
Sig. (2-tailed) .360 .326 .000 .011 . .876
Pearson 
Correlation .060 -.024 .174 -.123 .070 -------------CHANCE MHLOC 
Sig. (2-tailed) .383 .906 .385 .542 .728 .
** Correlation is significant at the 0.01 level (2-tailed). 
* Correlation is significant at the 0.05 level (2-tailed).  
Note.  Values above the main diagonal are for RBC women.  Values below the diagonal are for IBC 
women.   
 






Correlation Matrix between Health Lcus of Control and  Functional QL for IBC  
 

















Correlation --------  .186 .197 .390(*) .029 -.008FUNCT. 
QL Sig. (2-tailed)  
 . .177 .324 .044 .887 .971 
Pearson 
Correlation .035 -------- .504(**) .307 .574(**) -.030INT. 
MHLOC Sig. (1-tailed) IBC 
Sig. (2-tailed) RBC .431 . .006 .112 .001 .880
Pearson 
Correlation .311 -.048 ------------ .561(**) .763(**) .349
POWER 
 
MHLOC Sig. (2-tailed) .114 .813 . .002 .000 .074 
Pearson 
Correlation .464(*) -.132 .713(**) --------- .038 .275DOC  
MHLOC 
Sig. (2-tailed) .015 .511 .000 . .850 .165 
Pearson 
Correlation .223 .197 .893(**) .479(**) ------------ .031PEOPLE 
MHLOC 
Sig. (2-tailed) .263 .326 .000 .011 . .876 
Pearson 
Correlation .037 -.024 .174 -.123 .070 -------------CHANCE MHLOC 
Sig. (2-tailed) .856 .906 .385 .542 .728 . 
** Correlation is significant at the 0.01 level (2-tailed).  
* Correlation is significant at the 0.05 level (2-tailed).  
Note.  Values above the main diagonal are for RBC women.  Values below the diagonal are for IBC 
women.   
IBC and RBC for Functional QL and Internal MHLOC are 1-tailed tests. 
 







Qualitative Analysis of Frequencies Separated by IBC and RBC  
 
for Open-ended Questions 
            
        Frequency Percent  
 
How Has Cancer Impacted Life? 
 
Health  
 IBC   RBC   
Fear of recurrence      3       13.0     1    4.3 
Constantly aware of health         0      0.0    1       4.3 
Focus on health eating and exercise         2    8.7     1    4.3 
At the mercy of medical community      1       4.3    0    0.0 
Fear of developing Lymphodema      1       4.3    0      0.0 
Health is not the same since diagnosis      0         0.0     2    8.7 
and treatment of cancer 
Category not used  16       69.6      18    69.6 
Total       23      100.0      23  100.0 
 
 
Psychological Functioning  
 
        IBC          RBC 
 
 
Initially devastating      1         4.3     2     8.7 
Scary       0        0.0     1    4.3 
Loss of control of life      1        4.3     0    0.0 
Negativism      0        0.0     1    4.3  
Depression      3       13.0     0    0.0 
Anxiety      0        0.0     1    4.3 
Coping with life better      0        0.0     1    4.3 
Difficulty getting on with life      1        4.3     0    0.0 
Life more stressful      1        4.3     0    0.0 
Category not used      16       69.6      17      73.9 






Table 10   (continued). 
                           
          Frequency   Percent      
  
Functional Well-being  
 
        IBC         RBC 
Can’t do everything used to       4       17.4     2    8.7 
Decreased mobility      3       13.0     2    8.7 
More open to receiving help from others      0         0.0     1    4.3 
Treatment side-effects problematic      1         4.3     1    4.3 
Fatigued      3       13.0     1    4.3 
In pain       1         4.3     0    0.0 
Employment difficulties      3       13.0     0    0.0 
Category not used          8       34.8      16      69.6 
Total       23     100.0      23    100.0 
 
Outlook on Life  
 
        IBC          RBC 
Different outlook on life      3       13.0      5    21.7 
Created a positive effect on life      2         8.7     4    17.4 
Realized mortality      2         8.7     1    4.3 
Life not the same as before      0         0.0     1    4.3 
Enjoy life more      2         8.7     2    8.7 
Live in the here and now      1         4.3     1    4.3 
Learn to say, “No”      1         4.3     1    4.3 
More aware that others are ill      2         8.7     0    0.0 
Uncertainty of future      1         4.3       0    0.0 
Category not used     9       39.1        8     34.8 




               IBC         RBC  
Social Functioning      2         8.7     2    8.7 
Family        1         4.3     2    8.7 
Optimism      2         8.7     1    4.3 
Insurance concerns      0         0.0     1     4.3 
Self Care      0         0.0     1    4.3 
Engage in Activities      0         0.0     1      4.3 
Category not used        9       39.1     4    60.9 






Qualitative Analysis of Frequencies Separated by IBC and RBC  
 
for Open-ended Questions 
                           
        Frequency   Percent       
 




        IBC         RBC 
Health is not the same since diagnosis      1         4.0    1    4.0 
and treatment of cancer 
Fear of recurrence      0         0.0     1    4.0 
Fear of developing Lymphodema      0         0.0     1    4.0 
Never thought would get cancer      0         0.0      1    4.0 
Category not used                                                               24       96.0     21     84.0 




         IBC       RBC   
 
Thankful to God      1         4.0      1    4.0 
Help heal self spiritually      1         4.0       0    0.0 
Engage in prayer more      1         4.0       0    0.0 
Led to believe in God      0         0.0      1    4.0 
Brought closer to God      0         0.0      2      8.0 
Category not used       22       88.0        21    84.0 
Total        25     100.0        25  100.0 
 
Social Functioning  
 
                IBC         RBC  
 
Appreciate friends/family more      5       20.0       0    0.0 
More involved helping others now      2         8.0    0    0.0 
Category not used       18       72.0        25  100.0 








Table 11  (continued). 
                           




            IBC         RBC 
Brought family closer      2          8.0     1   4.0 
Grown closer to husband      0     0.0   1   4.0 
Sad because children are hurting      0    0.0     1   4.0 
Created stress within family      1    4.0     0   0.0 
Concerns about being able to raise 
children      1       4.0          0   0.0 
Category not used      21        84.0        22   88.0 
Total       25      100.0        25 100.0 
 
Functional Well-being  
 
           IBC       RBC 
Relax More      1          4.0   1   4.0 
Can’t do everything used to       0    0.0     2   8.0 
Fatigued      0    0.0     4    16.0 
Treatment side-effects problematic      1    4.0     0     0.0 
In pain       1    4.0     1 4.0 
Employment difficulties      0    0.0     1   4.0 
Category not used        22        88.0         1   100.0 
Total      25      100.0       25   100.0 
 
Outlook on Life  
 
           IBC         RBC 
Different outlook on life      5        20.0    2     8.0 
Created a positive effect on life      2    8.0    3        12.0 
Realized mortality      0    0.0    1     4.0 
Enjoy life more      4        16.0    2     8.0 
Live in the here and now      2    8.0    1     4.0 
Learn to say, “No”      1    4.0    0     0.0 
More aware that others are ill      1    4.0    1     4.0 
More organized      0    0.0    1     4.0 
Can’t forget have cancer      0    0.0    1     4.0 
Don’t get as stressed out      3        12.0    0     0.0 
Read more to better life      1    4.0    0     0.0 
Category not used           6        24.0     13        52.0 





Table 11 (continued). 
                           
        Frequency   Percent      
      
Other  
           IBC         RBC 
 
Body Image      1    4.0    2     8.0 
Insurance concerns      0    0.0    1     4.0 
Financial concerns      1    4.0    0     0.0 
Self care      1    4.0    0     0.0 
Optimism      0    0.0    1     4.0 
Engage in activities      2    8.0    1     4.0 
Employment difficulties      0    0.0    1     4.0 
Category not used        20       80.0     17        80.0 
Total      25    100.0     25      100.0     
 











Qualitative Analysis of Frequencies Separated by IBC and RBC  
 
for Open-ended Questions 
                           
        Frequency   Percent       
 
Additional Comments  
 
Health  
                IBC         RBC 
 
Fear of recurrence      2       18.2     0          0.0 
Fear of developing Lymphodema      1      9.1     0        0.0 
Category not used        8       72.7  17 100.0  
Total      11     100.0      17      100.0 
 
 
Medical Care/Research Concerns  
 
                IBC         RBC 
 
Support clinical trials/new medications      1         9.1     0      0.0 
Doctor is uncaring        1      9.1     0     0.0  
Good doctor/psychologist/nurse care      0      0.0     4        23.5 
Doctors’ need to emphasize entire body, 
not just right/left breast      0      0.0     1     5.9 
Educate patients about biopsies      1      9.1     0       0.0 
More education regarding Lymphodema,  
     Tamoxifen, and what to do after treatment      4       36.3     0     0.0 
Psychosocial, emotional, spiritual aspect of 
     cancer survival is neglected      1      9.1     0     0.0 
Need to find a cure      0      0.0     1      5.9 
Patient first to know that something is  
wrong then doctor      0      0.0     1     5.9 
Category not used        3       27.3       10       58.0 









Table 12 (continued). 
                           




                IBC         RBC 
 
Engage in prayer      1       9.1     0     0.0 
Faith in God      2       18.2     7        41.2 
Faith in God helps with coping      0      0.0     1     5.9 
Prayers of others have helped      0      0.0     1     5.9 
Category not used        8       72.7         8        47.0 
Total     11     100.0       17      100.0 
 
 
Psychological Functioning  
 
                IBC       RBC 
 
Anger       1     9.1     1     5.9 
Fear of depending on others      1   9.1     1     5.9 
Depression      0   0.0     2        11.7 
More afraid now than ever      0   0.0     2        11.7 
Need to vent emotions      0   0.0     1     5.9 
Stress       0   0.0     1     5.9 
Category not used      9     81.8          9        52.9 
Total      11   100.0        17      100.0 
 
Functional Well-being  
 
                IBC         RBC 
 
Can’t do everything used to       0   0.0     1     5.9 
Fatigued      0   0.0     3        17.6 
Engage in Activities      0   0.0     1     5.9 
Category not used         11    100.0       12        70.6 









Table 12 (continued). 
                           
        Frequency   Percent       
 
Outlook on Life  
 
                IBC         RBC 
Realize mortality      1   9.1     1     5.9 
Enjoy life more      1   9.1     1     5.9 
Cancer is a 2nd chance at life      1   9.1     1     5.9 
Makes you re-evaluate life      0   0.0     1     5.9 
Category not used         8      72.7       13        76.4 





                IBC         RBC 
 
Body Image      1   9.1     0     0.0 
Self care      1   9.1     0     0.0 
Optimism      0   0.0     4        23.5 
Social Support         1   9.1     4        23.5 
Insurance concerns       1   9.1     1     5.9 
Financial concerns      0   0.0     1     5.9 
Social Functioning      1   9.1          3        17.6 
Family       1   9.1     1     5.9 
Category not used        5      45.4          3        17.6 






























































































































    
      















   








   
   
   
   
   





























   







   
   























   
   
































   
   
   
   






























































   






































































































































































































































 Your doctor has agreed to present you with the opportunity to participate in a 
study assessing mental and physical factors that affect women with breast cancer. We 
hope to use this information to better understand the factors that affect the recurrent 
cancer experience and to provide insight to develop interventions to improve the quality 
of life for recurrent cancer patients like you.  Your participation will involve completing 
a questionnaire that will take approximately 30 minutes.   Participation is voluntary and 
anonymous.  Completion of the questionnaire will be considered your consent to 
participate.  All information will be kept completely confidential.  We ask that you do not 
identify yourself in any way on the questionnaire.  When the questionnaire is completed, 
place it in the enclosed envelope, seal it, and return it to Julia. 
 
 You are free to stop participation at any time without penalty.  If you chose not to 
participate or to stop and withdraw from the study, it will not affect you or the services 
you receive in any way. We hope you will participate, as this information will increase 
our understanding of factors that influence how women perceive a cancer recurrence.  If 
you desire, we will provide your support group with a summary of findings when 
completed. 
 
 You might experience minimal psychological upset as the content of items in the 
questionnaire that deal with cancer and health. If you should experience upset from the 
content of the questionnaire, the researcher, a doctoral student in Clinical Psychology, 
would like to help and discuss these concerns with you.  If you experience any distress as 
a result of participating in this study or if you would like further information about the 
study or its results, please contact the researchers, Gina Graci, at (817) 361-9892 or the 
supervisor, Dr. Charles Guarnaccia, at the University of North Texas Department of 





            
Gina M. Graci, M.S.     Charles A. Guarnaccia, Ph.D. 
Researcher       Research Supervisor 
 
 
THIS PROJECT HAS BEEN REVIEWED BY UNIVERSITY OF NORTH TEXAS 
COMMITTEE FOR THE PROTECTION OF HUMAN SUBJECTS  






(Recurrent Breast Cancer Participants) 
 
 
Dear Support Group Participant, 
 
 Your group has agreed to present you with the opportunity to participate in a 
study assessing the mental and physical factors that affect women with recurrent breast 
cancer. We hope to use this information to better understand the factors that affect the 
recurrent cancer experience and to provide the insight to develop interventions to 
improve the quality of life for recurrent cancer patients like you.  Your participation will 
involve completing a questionnaire that will take approximately 30 minutes.   
Participation is voluntary and anonymous.  Completion of the questionnaire will be 
considered your consent to participate.  All information will be kept completely 
confidential.  We ask that you do not identify yourself in any way on the questionnaire.  
When the questionnaire is completed, place it in the enclosed envelope, seal it, and return 
it to your support group facilitator. 
 
 You are free to stop your participation at any time without penalty.  If you chose 
not to participate or to withdraw from the study, it will not affect you or the services you 
receive in any way. We hope you will participate as this information will increase our 
understanding of factors that influence how women perceive a cancer recurrence. If you 
desire, we will provide your support group with a summary of findings when completed. 
 
 You might experience minimal psychological upset as the content of items in the 
questionnaire that deal with cancer and health. If you should experience upset from the 
content of the questionnaire, the researcher, a doctoral student in Clinical Psychology, 
would like to help and discuss these concerns with you.  If you experience any distress as 
a result of participating in this study or if you would like further information about the 
study or its results, please contact the researchers, Gina Graci at (817) 361-9892 or the 
supervisor, Dr. Charles Guarnaccia at the University of North Texas Department of 
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(Initial Breast Cancer Participants) 
 
 
Dear Support Group Participant, 
 
 Your group has agreed to present you with the opportunity to participate in a 
study assessing the mental and physical factors that affect women with breast cancer. We 
hope to use this information to better understand the factors that affect the cancer 
experience and to provide the insight to develop interventions to improve the quality of 
life for cancer patients like you.  Your participation will involve completing a 
questionnaire that will take approximately 30 minutes.   Participation is voluntary and 
anonymous.  Completion of the questionnaire will be considered your consent to 
participate.  All information will be kept completely confidential.  We ask that you do not 
identify yourself in any way on the questionnaire.  When the questionnaire is completed, 
place it in the enclosed envelope, seal it, and return it to your support group facilitator. 
 
 You are free to stop your participation at any time without penalty.  If you chose 
not to participate or to withdraw from the study, it will not affect you or the services you 
receive in any way. We hope you will participate as this information will increase our 
understanding of factors that influence how women perceive cancer. If you desire, we 
will provide your support group with a summary of findings when completed. 
 
 You might experience minimal psychological upset as the content of items in the 
questionnaire that deal with cancer and health. If you should experience upset from the 
content of the questionnaire, the researcher, a doctoral student in Clinical Psychology, 
would like to help and discuss these concerns with you.  If you experience any distress as 
a result of participating in this study or if you would like further information about the 
study or its results, please contact the researchers, Gina Graci at (817) 361-9892 or the 
supervisor, Dr. Charles Guarnaccia at the University of North Texas Department of 
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Please answer these questions regarding your personal history as well as some medical 
information.  Do not write your name on this form or identify yourself in any way. 
Your age:    
Stage of Cancer (Stage I, II, III, IV)    
I.     Please check the one that applies to you in each item: 
       1.  Marital Status: 
  Married            Separated/Divorced            Widowed            Single (never married)        
        Relationship To You Of Those In Your Household? 
             
            Relationship           Age            Relationship           Age            Relationship        Age 
             
 Relationship           Age            Relationship           Age            Relationship        Age 
             
 Relationship           Age            Relationship           Age            Relationship        Age 
 
        2. Your Ethnicity: 
         White            African American            Hispanic           Asian American       Other   
        3.   Spouse/Partner’s Ethnicity: 
  White            African American            Hispanic           Asian American       Other   
        4.  Your Education: 
             Eighth Grade     High School Diploma               Trade School         Some College      
               College Degree          Some Graduate/Professional School         Graduate/Professional Degree      
       5.  Spouse/Partner’s Education: 
             Eighth Grade     High School Diploma               Trade School         Some College      
               College Degree          Some Graduate/Professional School         Graduate/Professional Degree  
        6.  Employment: 
Currently Employed Full-Time       
Currently Employed Part-Time         
Currently Not Working Due To Illness    
Currently Not employed outside of the home     
If Currently Not Employed, Is This Due To Illness?  Yes          No               
When Did You Stop Working?         
Current/Past Employment          





         7. Spouse/Partner’s:  
    Current/Past Employment          
    Retired     When?                                    
         8.  Medical Information: 
   Number of Cancer Diagnoses    
  I. Date of First Diagnosis      
    Type of Cancer (First Diagnosis)       
 Treatment Received For First Diagnosis (Check All That Apply) 
                  Surgery    
        Chemotherapy                
         Radiation Therapy       
         Bone Marrow Transplant    
         Other (Please Specify)         
         How Long Did Treatment Last?        
    II. Date of Second Diagnosis          
    Type of Cancer (For Second Diagnosis)        
     Treatment Received For Second Diagnosis (Check All That Apply) 
                   Surgery    
        Chemotherapy                       
         Radiation Therapy               
         Bone Marrow Transplant    
         Other (Please Specify)         
                   How Long Did Treatment Last?        
  Is this treatment still on-going?   Yes        No         
    III. Any Additional Diagnosis?   Yes        No              
     Type            
     Treatment Received         
             
        8.  How Has Your Cancer Impacted Your Life?            
            
            
             
        9.  What Is The Most Significant Way Cancer Has Impacted Your Life?     
            
            








Please answer all the following questions by circling the number that best represents your 
response.  Remember there are no right or wrong answers. 
 
1. Most people experience some feelings of depression at times.  Rate how   
often you feel these feelings. 
 
1 2 3 4 5 6 7  
  Never      All The Time 
 
 
2. How well are you coping with your everyday stress? 
 
1 2 3 4 5 6 7  
      Very Poorly             Very Well 
 
 
3. How much time do you spend thinking about your illness? 
 
1 2 3 4 5 6 7  
  Never            Constantly 
 
4. Rate your ability to maintain your usual recreation or leisure activities. 
 
1 2 3 4 5 6 7  
           Not Able            Very Able 
  At All 
 
5. Has nausea affected your daily functioning? 
 
1 2 3 4 5 6 7  
         Not At All          A Great Deal 
 
6. How well do you usually feel? 
 
1 2 3 4 5 6 7  
     Extremely Bad         Extremely Well 
 
7. How often do you feel well enough to make a meal or do minor household 
chores? 
 
1 2 3 4 5 6 7  





8. Rate the degree to which your cancer has imposed a hardship on those   
closest to you. 
 
1 2 3 4 5 6 7  
        No Hardship          Tremendous  
  At All             Hardship 
 
9. Rate how often you feel discouraged about your life. 
 
1 2 3 4 5 6 7  
  Never      Always 
 
10. Rate your satisfaction with your jobs and work around the house since the 
diagnosis. 
 
1 2 3 4 5 6 7  
    Very       Very 
  Dissatisfied     Satisfied 
 
11. How uncomfortable do you usually feel? 
 
1 2 3 4 5 6 7  
    Very        Very 
      Uncomfortable           Comfortable 
 
12. Rate in your opinion, how disruptive your cancer has been to those   
closest to you since the diagnosis? 
 
1 2 3 4 5 6 7  
       Not Disruptive     Totally 
  At All              Disruptive 
 
13.  How much is pain or discomfort interfering with your daily activities? 
  
1 2 3 4 5 6 7  
         Not At All            A Great Deal 
 
14.  Rate the degree to which your cancer has imposed a hardship on you (personally) 
since the diagnosis. 
 
1 2 3 4 5 6 7  
       No Hardship     Tremendous 





15.   How much of your usual household tasks are you able to complete? 
 
1 2 3 4 5 6 7  
    None         All 
 
16.   Rate how willing you are to see and spend time with those closest 
  to you? 
 
1 2 3 4 5 6 7  
    Very        Very 
  Unwilling     Willing 
 
17. How much nausea did you have (or do you have) during chemotherapy? 
 
1 2 3 4 5 6 7  
   None            A Great Deal 
 
18. Rate the degree to which you are frightened of the future. 
 
1 2 3 4 5 6 7  
         Not Afraid              Constantly 
  At All          Afraid 
 
19. Rate how willing usually you are to see and spend time with friends. 
 
1 2 3 4 5 6 7  
    Very        Very 
           Unwilling     Willing 
 
20. How much of your pain or discomfort you have had since the diagnosis is  
related to your cancer? 
 
1 2 3 4 5 6 7  
    None          All 
 
21. Rate your confidence in your prescribed course of treatment. 
 
1 2 3 4 5 6 7  
       Not Confident       Very 
  At All              Confident 
 
22. How well do you usually appear? 
 
1 2 3 4 5 6 7  
          Extremely               Extremely 







For the next set of questions, please try to be as honest and accurate as you can 
throughout.  Try not to let your response to one statement influence your responses to 
other statements.  There are no “correct” or “incorrect” answers.  Answer according to 
your own feelings, rather than how you think “most people” would answer. 
 
 
1. In uncertain times, I usually expect the best. 
 
 0 I agree a lot 
 1 I agree a little 
 2 I neither agree nor disagree 
 3 I DISagree a little 
 4 I DISagree a lot  
 
2. It’s easy for me to relax. 
 
0 I agree a lot 
 1 I agree a little 
 2 I neither agree nor disagree 
 3 I DISagree a little 
 4 I DISagree a lot  
 
3. If something can go wrong for me, it will. 
 
 0 I agree a lot 
 1 I agree a little 
 2 I neither agree nor disagree 
 3 I DISagree a little 
 4 I DISagree a lot  
  
4. I always look on the bright side of things. 
 
0 I agree a lot 
 1 I agree a little 
 2 I neither agree nor disagree 
 3 I DISagree a little 











5. I’m always optimistic about my future. 
 
 0 I agree a lot 
 1 I agree a little 
 2 I neither agree nor disagree 
 3 I DISagree a little 
 4 I DISagree a lot  
 
6. I enjoy my friends a lot. 
 
 0 I agree a lot 
 1 I agree a little 
 2 I neither agree nor disagree 
 3 I DISagree a little 
4 I DISagree a lot  
 
 
7. It’s important for me to keep busy. 
 
 0 I agree a lot 
 1 I agree a little 
 2 I neither agree nor disagree 
 3 I DISagree a little 
 4 I DISagree a lot  
 
 
8. I hardly ever expect things to go my way. 
 
 0 I agree a lot 
 1 I agree a little 
 2 I neither agree nor disagree 
 3 I DISagree a little 
 4 I DISagree a lot  
 
 
9. Things never work out the way I want them to. 
 
0 I agree a lot 
 1 I agree a little 
 2 I neither agree nor disagree 
 3 I DISagree a little 







10. I don’t get upset too easily. 
 
 0 I agree a lot 
 1 I agree a little 
 2 I neither agree nor disagree 
 3 I DISagree a little 
 4 I DISagree a lot  
 
 
11. I’m a believer in the idea that “every cloud has a silver lining.” 
 
 0 I agree a lot 
 1 I agree a little 
 2 I neither agree nor disagree 
 3 I DISagree a little 
 4 I DISagree a lot  
 
12. I rarely count on good things happening to me. 
 
 0 I agree a lot 
 1 I agree a little 
 2 I neither agree nor disagree 
 3 I DISagree a little 
 4 I DISagree a lot  
 
13. Overall, I expect more good things to happen to me than bad. 
 
0 I agree a lot 
 1 I agree a little 
 2 I neither agree nor disagree 
 3 I DISagree a little 









Each item blow is a belief statement about your medical condition, with which you may 
agree or disagree.  Beside each statement is a scale which ranges from strongly disagree 
(1) to strongly agree (6).  For each item we would like you to circle the number that 
represents the extent to which you agree or disagree with each statement.  The more you 
agree with a statement, then the higher will the number you circle.  The more you 
disagree with a statement, then the lower will be the number you circle.  Please make sure 
that you answer EVERY ITEM and that you circle ONLY ONE number per item.  This is 
a measure of your personal beliefs; obviously, there are no right or wrong answers. 
 
1 = STRONGLY DISAGREE (SD)   4 = SLIGHTLY AGREE (A) 
2 = MODERATELY DISAGREE (MD)  5 = MODERATELY AGREE (MA) 
3 = SLIGHTLY DISAGREE (D)   6 = STRONGLY AGREE (SA) 
 
        SD   MD   D    A   MA   SA 
 
1.   If my cancer worsens, it is my own behavior which  1      2      3     4  5  6 
      determines how soon I feel better again. 
 
2.   As to my cancer, what will be will be. 1      2      3     4  5  6 
        
3. If I see my doctor regularly, I am less likely to have 1      2      3     4      5      6 
problems with my cancer. 
 
4.   Most things that affect my cancer happen to me by chance. 1      2      3     4      5      6 
 
5. Whenever my cancer worsens, I should consult a  1      2      3     4      5      6 
medically trained professional. 
 
6. I am directly responsible for my cancer getting better  1      2      3     4      5      6 
      or worse. 
 
7. Other people play a big role in whether my cancer  1      2      3     4      5      6 
improves, stays the same, or gets worse. 
 
8.   Whatever goes wrong with my cancer is my own fault. 1      2      3     4      5      6 
 
9. Luck plays a big part in determining how my cancer 1      2      3     4      5      6 
improves. 
 
10. In order for my cancer to improve, it is up to other  1      2      3     4      5      6 





11.  Whatever improvement occurs with my cancer is largely 1      2      3     4      5      6 
 a matter of good fortune. 
 
12.  The main thing which affects my cancer is what I myself do. 1      2      3     4      5      6 
 
13. I deserve the credit when my cancer improves and the  1      2      3     4      5      6 
 blame when it gets worse. 
 
14.  Following doctor’s orders to the letter is the best way to  1      2      3     4      5      6 
  to keep my cancer from getting any worse. 
 
15.  If my cancer worsens, it’s a matter of fate. 1      2      3    4      5      6 
 
16.  If I am lucky, my cancer will get better. 1      2      3     4      5      6 
  
17.  If my cancer takes a turn for the worse, it is because 1      2      3     4      5      6 
  I have not been taking proper care of myself. 
 
18. The type of help I receive from other people determines 1      2      3     4      5      6 







Thank you for taking the time to complete this questionnaire.  We would like to hear any 
comments you may have.  Please address any concerns on the space provided.  Again, thank you 
for your participation. 
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